MPD: Measures involving BXD

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Auwerx1:1	Auwerx1	body weight	high-fat diet	body weight at 8 wks of age [g] bw_8wks 111180 CD HFD	BXD w/par	57	m	8wks	N=5	2016

Auwerx1:3	Auwerx1	body weight	high-fat diet	body weight at 9 wks of age [g] bw_9wks 111182 CD HFD	BXD w/par	57	m	9wks	N=5	2016

Auwerx1:5	Auwerx1	body weight	high-fat diet	body weight at 10 wks of age [g] bw_10wks 111184 CD HFD	BXD w/par	57	m	10wks	N=5	2016

Auwerx1:7	Auwerx1	body weight	high-fat diet	body weight at 11 wks of age [g] bw_11wks 111186 CD HFD	BXD w/par	57	m	11wks	N=5	2016

Auwerx1:9	Auwerx1	body weight	high-fat diet	body weight at 12 wks of age [g] bw_12wks 111188 CD HFD	BXD w/par	57	m	12wks	N=5	2016

Auwerx1:11	Auwerx1	body weight	high-fat diet	body weight at 13 wks of age [g] bw_13wks 111190 CD HFD	BXD w/par	57	m	13wks	N=5	2016

Auwerx1:13	Auwerx1	body weight	high-fat diet	body weight at 14 wks of age [g] bw_14wks 111192 CD HFD	BXD w/par	57	m	14wks	N=5	2016

Auwerx1:15	Auwerx1	body weight	high-fat diet	body weight at 15 wks of age [g] bw_15wks 111194 CD HFD	BXD w/par	57	m	15wks	N=5	2016

Auwerx1:17	Auwerx1	body weight	high-fat diet	body weight at 16 wks of age [g] bw_16wks 111196 CD HFD	BXD w/par	57	m	16wks	N=5	2016

Auwerx1:19	Auwerx1	body weight	high-fat diet	body weight at 17 wks of age [g] bw_17wks 111198 CD HFD	BXD w/par	57	m	17wks	N=5	2016

Auwerx1:21	Auwerx1	body weight	high-fat diet	body weight at 18 wks of age [g] bw_18wks 111200 CD HFD	BXD w/par	57	m	18wks	N=5	2016

Auwerx1:23	Auwerx1	body weight	high-fat diet	body weight at 19 wks of age [g] bw_19wks 111202 CD High fat diet	BXD w/par	57	m	19wks	N=4	2016

Auwerx1:25	Auwerx1	body weight	high-fat diet	body weight at 20 wks of age [g] bw_20wks 111204 CD HFD	BXD w/par	55	m	20wks	N=4	2016

Auwerx1:27	Auwerx1	body weight	high-fat diet	body weight at 21 wks of age [g] bw_21wks 111206 CD HFD	BXD w/par	56	m	21wks	N=4	2016

Auwerx1:29	Auwerx1	body weight	high-fat diet	body weight at 22 wks of age [g] bw_22wks 111208 CD HFD	BXD w/par	57	m	22wks	N=4	2016

Auwerx1:31	Auwerx1	body weight	high-fat diet	body weight at 23 wks of age [g] bw_23wks 111210 CD HFD	BXD w/par	56	m	23wks	N=4	2016

Auwerx1:33	Auwerx1	body weight	high-fat diet	body weight at 24 wks of age [g] bw_24wks 111212 CD HFD	BXD w/par	26	m	24wks	N=4	2016

Auwerx1:35	Auwerx1	body weight	high-fat diet	body weight at 25 wks of age [g] bw_25wks 111214 CD HFD	BXD w/par	49	m	25wks	N=4	2016

Auwerx1:37	Auwerx1	body weight	high-fat diet	body weight at 26 wks of age [g] bw_26wks 111216 CD HFD	BXD w/par	53	m	26wks	N=4	2016

Auwerx1:39	Auwerx1	body weight	high-fat diet	body weight at 27 wks of age [g] bw_27wks 111218 CD HFD	BXD w/par	57	m	27wks	N=4	2016

Auwerx1:41	Auwerx1	body weight	high-fat diet	body weight at 28 wks of age [g] bw_28wks 111220 CD HFD	BXD w/par	57	m	28wks	N=4	2016

Auwerx1:43	Auwerx1	body weight	high-fat diet	body weight at pre-sacrifice, 29 wks of age [g] bw_presac 111222 CD HFD	BXD w/par	55	m	29wks	N=4	2016

Auwerx1:45	Auwerx1	body weight	high-fat diet	body weight at sacrifice, 29 wks of age [g] bw_sac 111224 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:47	Auwerx1	body weight	high-fat diet	body weight prior to respiration test, 16 wks of age [g] bw_resp 111226 CD HFD	BXD w/par	57	m	16wks	N=4	2016

Auwerx1:49	Auwerx1	NMR	high-fat diet	fat tissue mass, 16 wks of age [g] ftm_16wks 111228 CD HFD	BXD w/par	57	m	16wks	N=4	2016

Auwerx1:51	Auwerx1	NMR	high-fat diet	lean tissue mass, 16 wks of age [g] ltm_16wks 111230 CD HFD	BXD w/par	57	m	16wks	N=4	2016

Auwerx1:53	Auwerx1	intake monitoring	high-fat diet	food_intake_16wks [g/day] food_intake_16wks 111232 CD HFD	BXD w/par	45	m	16wks	N=4	2016

Auwerx1:55	Auwerx1	monitoring system	high-fat diet	respiratory exchange rate (VCO2:VO2), 24h test, during day [ratio] rer_day 111234 CD HFD	BXD w/par	53	m	16wks	N=4	2016

Auwerx1:57	Auwerx1	monitoring system	high-fat diet	respiratory exchange rate (VCO2:VO2), 24h test, during night [ratio] rer_night 111236 CD HFD	BXD w/par	53	m	16wks	N=4	2016

Auwerx1:59	Auwerx1	monitoring system	high-fat diet	oxygen consumption, 24h period, during day [mL/kg/min] vo2_day 111238 CD HFD	BXD w/par	53	m	16wks	N=4	2016

Auwerx1:61	Auwerx1	monitoring system	high-fat diet	oxygen consumption, 24h period, during night [mL/kg/min] vo2_night 111240 CD HFD	BXD w/par	53	m	16wks	N=4	2016

Auwerx1:63	Auwerx1	body weight	high-fat diet	body weight prior to oral glucose tolerance test (OGTT), 17 wks of age [g] bw_ogtt 111242 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:65	Auwerx1	glucose tolerance	high-fat diet	glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 111244 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:67	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 111246 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:69	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 111248 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:71	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 111250 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:73	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 111252 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:75	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 111254 CD HFD	BXD w/par	55	m	17wks	N=4	2016

Auwerx1:77	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 111256 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:79	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 111258 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:81	Auwerx1	glucose tolerance	high-fat diet	glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 111260 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:83	Auwerx1	glucose tolerance	high-fat diet	glucose, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_gluc_auc 111262 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:85	Auwerx1	hormone quantification	high-fat diet	insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 111264 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:87	Auwerx1	hormone quantification	high-fat diet	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 111266 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:89	Auwerx1	hormone quantification	high-fat diet	insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 111268 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:91	Auwerx1	hormone quantification	high-fat diet	insulin, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_ins_auc 111270 CD HFD	BXD w/par	57	m	17wks	N=4	2016

Auwerx1:93	Auwerx1	body weight	high-fat diet	body weight prior to non-invasive blood pressure, 19 wks of age [g] bw_bp 111272 CD HFD	BXD w/par	55	m	19wks	N=4	2016

Auwerx1:95	Auwerx1	tail cuff	high-fat diet	systolic blood pressure [mmHg] systolic_bp 111274 CD HFD	BXD w/par	57	m	19wks	N=4	2016

Auwerx1:97	Auwerx1	tail cuff	high-fat diet	diastolic blood pressure [mmHg] diastolic_bp 111276 CD HFD	BXD w/par	57	m	19wks	N=4	2016

Auwerx1:99	Auwerx1	tail cuff	high-fat diet	heart rate [n/min] hr 111278 CD HFD	BXD w/par	56	m	19wks	N=4	2016

Auwerx1:101	Auwerx1	body weight	high-fat diet	body weight prior to cold response test, 21 wks of age [g] bw_coldtest 111280 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:103	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 0h exposed to cold [°C] temp_t0 111282 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:105	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 1h exposed to cold [°C] temp_t1 111284 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:107	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 2h exposed to cold [°C] temp_t2 111286 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:109	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 3h exposed to cold [°C] temp_t3 111288 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:111	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 4h exposed to cold [°C] temp_t4 111290 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:113	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 5h exposed to cold [°C] temp_t5 111292 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:115	Auwerx1	body temperature	high-fat diet	body temperature (rectal) in cold (4°C) room, 6h exposed to cold [°C] temp_t6 111294 CD HFD	BXD w/par	57	m	21wks	N=4	2016

Auwerx1:117	Auwerx1	NMR	high-fat diet	fat tissue mass, 23 wks of age [g] ftm_23wks 111296 CD HFD	BXD w/par	52	m	23wks	N=4	2016

Auwerx1:119	Auwerx1	NMR	high-fat diet	lean tissue mass, 23 wks of age [g] ltm_23wks 111298 CD HFD	BXD w/par	52	m	23wks	N=4	2016

Auwerx1:121	Auwerx1	body weight	high-fat diet	body weight prior to basal activity test, at 23 wks of age [g] bw_basal 111300 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:123	Auwerx1	intake monitoring	high-fat diet	daily food intake, basal activity test, for 2 days, 23 wks of age [g/day] food_intake_23wks 111302 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:125	Auwerx1	monitoring system	high-fat diet	horizontal activity (beam breaks) at night, basal activity test, for 48h [n/h] horiz_act 111304 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:127	Auwerx1	monitoring system	high-fat diet	vertical activity (beam breaks) at night, basal activity test, for 48h [n/h] vert_act 111306 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:129	Auwerx1	monitoring system	high-fat diet	basal oxygen consumption, prior to first treadmill training [mL/kg/min] vo2_basal 111308 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:131	Auwerx1	monitoring system	high-fat diet	basal respiratory exchange ratio (RER), prior to first treadmill training (VCO2:VO2), 15 min time period, last 2 min analyzed [ratio] rer_basal 111310 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:133	Auwerx1	body weight	high-fat diet	body weight, prior to first treadmill training [g] bw_treadmill1 111312 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:135	Auwerx1	monitoring system	high-fat diet	maximum oxygen consumption, first treadmill training [mL/kg/min] vo2_max_treadmill1 111314 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:137	Auwerx1	treadmill endurance test	high-fat diet	distance traveled, first treadmill training [m] dist_treadmill1 111316 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:139	Auwerx1	monitoring system	high-fat diet	maximum respiratory exchange ratio (RER), first treadmill training (VCO2:VO2) [ratio] rer_max_treadmill1 111318 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:141	Auwerx1	running wheel monitoring	high-fat diet	distance traveled, voluntary wheel running test, last 24h [km] dist_wheel 111320 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:143	Auwerx1	running wheel monitoring	high-fat diet	speed (mean rpm), voluntary wheel running test, 24h [n/min] speed_wheel 111322 CD HFD	BXD w/par	36	m	23wks	N=4	2016

Auwerx1:145	Auwerx1	monitoring system	high-fat diet	basal oxygen consumption, after voluntary wheel running test [mL/kg/min] vo2_basal_wheel 111324 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:147	Auwerx1	NMR	high-fat diet	fat tissue mass, 25 wks of age [g] ftm_25wks 111326 CD HFD	BXD w/par	53	m	25wks	N=4	2016

Auwerx1:149	Auwerx1	NMR	high-fat diet	lean tissue mass, 25 wks of age [g] ltm_25wks 111328 CD HFD	BXD w/par	53	m	25wks	N=4	2016

Auwerx1:151	Auwerx1	body weight	high-fat diet	body weight, prior to second treadmill training, at 25 wks of age [g] bw_treadmill2 111330 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:153	Auwerx1	monitoring system	high-fat diet	maximum oxygen consumption, second treadmill training [mL/kg/min] vo2_max_treadmill2 111332 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:155	Auwerx1	treadmill endurance test	high-fat diet	distance traveled, second treadmill training [m] dist_treadmill2 111334 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:157	Auwerx1	monitoring system	high-fat diet	basal respiratory exchange ratio (RER), second treadmill training (VCO2:VO2) [ratio] rer_basal_treadmill2 111336 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:159	Auwerx1	monitoring system	high-fat diet	maximum respiratory exchange ratio (RER), second treadmill test (VCO2:VO2) [ratio] rer_max_treadmill2 111338 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:161	Auwerx1	metabolic panel	high-fat diet	blood alanine transaminase amount [U/L] ala_trans 111340 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:163	Auwerx1	metabolic panel	high-fat diet	blood alkaline phosphatase amount [U/L] alk_phosph 111342 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:165	Auwerx1	metabolic panel	high-fat diet	blood amylase amount [U/L] amylase 111344 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:167	Auwerx1	metabolic panel	high-fat diet	blood aspartate transaminase amount [U/L] asp_trans 111346 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:169	Auwerx1	metabolic panel	high-fat diet	blood bile acid amount [µmol/L] bile 111348 CD HFD	BXD w/par	38	m	29wks	N=3	2016

Auwerx1:171	Auwerx1	metabolic panel	high-fat diet	blood creatine kinase amount [U/L] creatine_kin 111350 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:173	Auwerx1	metabolic panel	high-fat diet	blood creatinine amount [µmol/L] creatinine 111352 CD HFD	BXD w/par	47	m	29wks	N=4	2016

Auwerx1:175	Auwerx1	lipid profile	high-fat diet	blood free fatty acids amount [mmol/L] fatty_acids 111354 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:177	Auwerx1	metabolic panel	high-fat diet	blood glucose amount [mmol/L] glu 111356 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:179	Auwerx1	lipid profile	high-fat diet	blood HDL amount [mmol/L] hdl 111358 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:181	Auwerx1	metabolic panel	high-fat diet	blood iron amount [µmol/L] iron 111360 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:183	Auwerx1	metabolic panel	high-fat diet	blood lactate amount [mmol/L] lactate 111362 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:185	Auwerx1	metabolic panel	high-fat diet	blood lactate dehydrogenase (LDH) amount [U/L] ldh 111364 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:187	Auwerx1	lipid profile	high-fat diet	blood LDL amount [mmol/L] ldl 111366 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:189	Auwerx1	metabolic panel	high-fat diet	total blood protein amount [g/L] protein 111368 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:191	Auwerx1	lipid profile	high-fat diet	blood total cholesterol amount [mmol/L] chol_tot 111370 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:193	Auwerx1	lipid profile	high-fat diet	blood triglyceride amount [mmol/L] triglyc 111372 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:195	Auwerx1	cell signaling molecule detection	high-fat diet	blood interferon gamma (INF gamma) amount [pg/mL] inf_gamma 111374 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:197	Auwerx1	cell signaling molecule detection	high-fat diet	blood interleukin-18 (IL-18) amount [pg/mL] il_18 111376 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:199	Auwerx1	cell signaling molecule detection	high-fat diet	blood interleukin-6 (IL-6) amount [pg/mL] il_6 111378 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:201	Auwerx1	cell signaling molecule detection	high-fat diet	blood interleukin-10 (IL-10) amount [pg/mL] il_10 111380 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:203	Auwerx1	cell signaling molecule detection	high-fat diet	blood interleukin-15 (IL-15) amount [pg/mL] il_15 111382 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:205	Auwerx1	cell signaling molecule detection	high-fat diet	blood monocyte chemoattractant protein 1 (MCP1) amount [pg/mL] mcp1 111384 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:207	Auwerx1	cell signaling molecule detection	high-fat diet	blood macrophage inflammatory protein 1 alpha subunit (MIP1 alpha) amount [pg/mL] mip1_alpha 111386 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:209	Auwerx1	cell signaling molecule detection	high-fat diet	blood macrophage inflammatory protein 1 beta subunit (MIP1 beta) amount [pg/mL] mip1_beta 111388 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:211	Auwerx1	cell signaling molecule detection	high-fat diet	blood regulated on activation, normal T cell expressed and secreted (RANTES) protein amount [pg/mL] rantes 111390 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:213	Auwerx1	cell signaling molecule detection	high-fat diet	blood tumor necrosis factor alpha (TNF alpha) amount [pg/mL] tnf_alpha 111392 CD HFD	BXD w/par	33	m	29wks	N=4	2016

Auwerx1:215	Auwerx1	complete blood count	high-fat diet	hematocrit (HCT) [%] hct 111394 CD HFD	BXD w/par	31	m	29wks	N=4	2016

Auwerx1:217	Auwerx1	complete blood count	high-fat diet	red blood cell count (RBC; per volume x 10⁶) [n/µL] rbc 111396 CD HFD	BXD w/par	31	m	29wks	N=4	2016

Auwerx1:219	Auwerx1	organ weights	high-fat diet	epididymal fat pad weight [g] epid_fat_wt 111398 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:221	Auwerx1	organ weights	high-fat diet	skeletal muscle weight [g] muscle_wt 111400 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:223	Auwerx1	organ weights	high-fat diet	heart weight [g] heart_wt 111402 CD HFD	BXD w/par	56	m	29wks	N=4	2016

Auwerx1:225	Auwerx1	organ weights	high-fat diet	kidney weight (both) [g] kidney_wt 111404 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:227	Auwerx1	organ weights	high-fat diet	liver weight [g] liver_wt 111406 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:229	Auwerx1	organ weights	high-fat diet	perirenal white adipose tissue [g] perirenal_wt 111408 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:231	Auwerx1	organ weights	high-fat diet	subcutaneous adipose tissue weight [g] subcut_adip_wt 111410 CD HFD	BXD w/par	54	m	29wks	N=4	2016

Auwerx1:233	Auwerx1	organ weights	high-fat diet	soleus muscle weight [g] soleus_wt 111412 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Chesler1:1	Chesler1	nociception assay	(none)	latency of nociception to mechanical pressure on the tail [s] TC 34801	BXD	61	both	7-15wks	N=7	2010

Chesler1:10	Chesler1	nociception assay	(none)	mean sensory threshold eliciting withdrawal response from both hindfeet, Von Frey test days 1 and 2 [mN] VF 34810	BXD	61	both	7-15wks	N=6	2010

Chesler1:19	Chesler1	nociception assay	(none)	mean latency of both hindpaws to withdraw, Hargreaves test trials 1-3 [s] mean_HT 34819	BXD	61	both	7-15wks	N=6	2010

Chesler1:23	Chesler1	nociception assay	(none)	mean latency of tail withdrawal to thermal stimulation (trials 1, 2, 3) [s] mean_TW 34823	BXD	61	both	7-15wks	N=7	2010

Chesler1:29	Chesler1	nociception assay	(none)	mean latency of nociceptive response to hot plate (transformed) [s] mean_logN_HP 34829	BXD	61	both	7-15wks	N=6	2010

Crusio1:1	Crusio1	body weight	(none)	body weight [g] bw 62001	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:3	Crusio1	open field test	(none)	percentage of total time spent in center, 20 min test [%] center_time 62003	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:4	Crusio1	open field test	(none)	distance run in center, 20 min test [cm] center_dist 62004	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:5	Crusio1	open field test	(none)	percentage of total time spent in thigmotaxis zone, 20 min test [%] periphery_time 62005	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:6	Crusio1	open field test	(none)	distance run in thigmotaxis zone, 20 min test [cm] periphery_dist 62006	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:7	Crusio1	open field test	(none)	percentage of total distance run in thigmotaxis zone, 20 min test [%] periphery_dist_pct 62007	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:8	Crusio1	open field test	(none)	total locomotor activity, 20 min test [cm] activity 62008	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:9	Crusio1	open field test	(none)	number of leanings against wall, 20 min test [n] lean 62009	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:10	Crusio1	open field test	(none)	number of rearings, forepaws not resting against wall, 20 min test [n] rear 62010	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:11	Crusio1	open field test	(none)	number of jumps (all 4 paws leave floor), 20 min test [n] jump 62011	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:12	Crusio1	open field test	(none)	number of fecal boli deposited, 20 min test [n] defec 62012	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:13	Crusio1	open field test	(none)	frequency of bouts of grooming, 20 min test [n] groom_freq 62013	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:14	Crusio1	open field test	(none)	total duration of grooming, 20 min test [s] groom_dur 62014	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:15	Crusio1	open field test	(none)	mean duration of grooming bouts, 20 min test [s] groom_bout 62015	BXD w/par	55	both	10-12wks	N=8	2018

Crusio1:16	Crusio1	radial maze	(none)	time to complete task [s] task_time 62016 day 1 day 2 day 3 day 4 day 5	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:21	Crusio1	radial maze	(none)	number of different arms visited during first 8 arm choices of a trial [n] num_arms 62021 day 1 day 2 day 3 day 4 day 5	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:26	Crusio1	radial maze	(none)	number of different arms visited during first 8 arm choices of a trial minus 5.3 (number expected by chance) [n] num_arms_adj 62026 day 3 day 4 day 5 mean	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:30	Crusio1	radial maze	(none)	number of errors made before all 8 rewards collected [n] errors 62030 day 1 day 2 day 3 day 4 day 5 sum of days 3 4 5	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:36	Crusio1	radial maze	(none)	mean duration per arm visit (including errors) [s] visit_time 62036 day 3 day 4 day 5 mean	BXD w/par	55	both	10-13wks	N=8	2018

Crusio1:40	Crusio1	behavior observation	(none)	attack latency [s] latency 62040 day 1 day 2	BXD w/par	55	m	12-16wks	N=8	2018

Crusio1:42	Crusio1	behavior observation	(none)	whether an animal attacks (0=no, 1=yes) [score] attack 62042 day 1 day 2	BXD w/par	55	m	12-16wks	N=8	2018

Crusio1:44	Crusio1	behavior observation	(none)	whether an animal attacks (0=not either day, 1=yes on one or both days) [score] attack_combine 62044	BXD w/par	54	m	12-16wks	N=8	2018

Crusio1:45	Crusio1	organ weights	(none)	brain weight [g] brain_wt 62045	BXD w/par	55	both	12-16wks	N=8	2018

Crusio1:46	Crusio1	organ weights	(none)	brain weight as percentage of total body weight [%] brain_wt_pct 62046	BXD w/par	55	both	12-16wks	N=8	2018

Crusio1:48	Crusio1	histopathology	(none)	total hippocampus size (arbitrary units) hippocampus 62048 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:50	Crusio1	histopathology	(none)	size of intra- and infrapyramidal mossy fibers (arbitrary units) iipmf 62050 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:52	Crusio1	histopathology	(none)	percentage of hippocampus that is Intra- and infrapyramidal mossy fibers [%] iipmf_pct 62052 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:55	Crusio1	histopathology	(none)	size of hilus (arbitrary units) hilus 62055 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:57	Crusio1	histopathology	(none)	percentage of hippocampus that is hilus [%] hilus_pct 62057 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:60	Crusio1	histopathology	(none)	size of suprapyramidal mossy fibers (arbitrary units) supra 62060 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:62	Crusio1	histopathology	(none)	percentage of hippocampus that is suprapyramidal mossy fibers [%] supra_pct 62062 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:65	Crusio1	histopathology	(none)	size of stratum pyramidale (arbitrary units) pyr 62065 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:67	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum pyramidale [%] pyr_pct 62067 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:70	Crusio1	histopathology	(none)	size of stratum oriens (arbitrary units) oriens 62070 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:72	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum oriens [%] oriens_pct 62072 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:75	Crusio1	histopathology	(none)	size of stratum radiatum (arbitrary units) rad 62075 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:77	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum radiatum [%] rad_pct 62077 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:80	Crusio1	histopathology	(none)	size of stratum lacunosum-moleculare (arbitrary units) lacun 62080 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:82	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum lacunosum-moleculare [%] lacun_pct 62082 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

CSNA01:1	CSNA01	operant conditioning chamber	sucrose	fixed ratio 1 (FR1), active lever presses, 8 h test [n] FR1active 60201 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:6	CSNA01	operant conditioning chamber	sucrose	fixed ratio 1 (FR1), lever press rate, 8 h test [n/s] FR1rate 60206 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:11	CSNA01	operant conditioning chamber	sucrose	variable ratio 2 (VR2), active lever presses, 8 h test [n] VR2active 60211 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:16	CSNA01	operant conditioning chamber	sucrose	variable ratio 2 (VR2), lever press rate, 8 h test [n] VR2rate 60216 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:21	CSNA01	operant conditioning chamber	sucrose	variable ratio 5 (VR5), active lever presses, 8 h test [n] VR5active 60221 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:26	CSNA01	operant conditioning chamber	sucrose	variable ratio 5 (VR5), lever press rate, 8 h test [n/s] VR5rate 60226 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:31	CSNA01	operant conditioning chamber	sucrose	active lever presses, 8 h test [n] Actives 60231 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:41	CSNA01	operant conditioning chamber	sucrose	reinforcers earned, 8 h test [n] Reinfs 60241 day 1 day 2 day 3 across 3 days	HMDP	91	m	7-22wks	N=4	2018

CSNA01:51	CSNA01	operant conditioning chamber	sucrose	time elapsed before first reinforcer earned, 8 h test [s] FirstReinf 60251	HMDP	91	m	7-22wks	N=4	2018

CSNA01:52	CSNA01	operant conditioning chamber	sucrose	time elapsed between earning first and fiftieth reinforcer, 8 h test [s] Time1to50 60252	HMDP	82	m	7-22wks	N=3	2018

CSNA01:53	CSNA01	operant conditioning chamber	sucrose	whether criterion of 50 reinforcers earned was met, 8 h test (1=yes, 0=no) [score] Learned 60253	HMDP	91	m	7-22wks	N=4	2018

CSNA01:61	CSNA01	body weight	(none)	body weight prior to testing [g] bw_pre 60261	HMDP	85	m	7-22wks	N=4	2018

CSNA01:71	CSNA01	body weight	sucrose	percentage of starting body weight [%] bw 60271 day 1 before day 1 after day 2 before day 2 after day 3 before day 3 after (2 more)...	HMDP	84	m	7-22wks	N=4	2018

Dickson3:1	Dickson3	None	(none)	COC_IVSA_SES_TO_ACQ COC_IVSA_SES_TO_ACQ 121577	BXD w/par	26	m			2016

Dickson3:2	Dickson3	None	(none)	SE SE 121578	BXD w/par	13	m			2016

Dickson3:3	Dickson3	None	(none)	n n 121579	BXD w/par	26	m			2016

Dickson3:4	Dickson3	None	(none)	COC_IVSA_IDL COC_IVSA_IDL 121580	BXD w/par	26	m			2016

Dickson3:5	Dickson3	None	(none)	SE.1 SE.1 121581	BXD w/par	13	m			2016

Dickson3:6	Dickson3	None	(none)	n.1 n.1 121582	BXD w/par	26	m			2016

Dickson3:7	Dickson3	None	(none)	COC_IVSA_IAL COC_IVSA_IAL 121583	BXD w/par	26	m			2016

Dickson3:8	Dickson3	None	(none)	SE.2 SE.2 121584	BXD w/par	17	m			2016

Dickson3:9	Dickson3	None	(none)	n.2 n.2 121585	BXD w/par	26	m			2016

Dickson3:10	Dickson3	None	(none)	COC_IVSA_CAL COC_IVSA_CAL 121586	BXD w/par	28	m			2016

Dickson3:11	Dickson3	None	(none)	SE.3 SE.3 121587	BXD w/par	17	m			2016

Dickson3:12	Dickson3	None	(none)	n.3 n.3 121588	BXD w/par	28	m			2016

Dickson3:13	Dickson3	None	(none)	COC_IVSA_INFUS_0.032 COC_IVSA_INFUS_0.032 121589 COC_IVSA_INFUS_0.032	BXD w/par	33	m			2016

Dickson3:14	Dickson3	None	(none)	SE.4 SE.4 121590 SE.4	BXD w/par	22	m			2016

Dickson3:15	Dickson3	None	(none)	n.4 n.4 121591 n.4	BXD w/par	33	m			2016

Dickson3:16	Dickson3	None	(none)	COC_IVSA_INFUS_0.056 COC_IVSA_INFUS_0.056 121592 COC_IVSA_INFUS_0.056	BXD w/par	33	m			2016

Dickson3:17	Dickson3	None	(none)	SE.5 SE.5 121593 SE.5	BXD w/par	23	m			2016

Dickson3:18	Dickson3	None	(none)	n.5 n.5 121594 n.5	BXD w/par	33	m			2016

Dickson3:19	Dickson3	None	(none)	COC_IVSA_INFUS_0.1 COC_IVSA_INFUS_0.1 121595 COC_IVSA_INFUS_0.1	BXD w/par	36	m			2016

Dickson3:20	Dickson3	None	(none)	SE.6 SE.6 121596 SE.6	BXD w/par	27	m			2016

Dickson3:21	Dickson3	None	(none)	n.6 n.6 121597 n.6	BXD w/par	36	m			2016

Dickson3:22	Dickson3	None	(none)	COC_IVSA_INFUS_0.18 COC_IVSA_INFUS_0.18 121598 COC_IVSA_INFUS_0.18	BXD w/par	34	m			2016

Dickson3:23	Dickson3	None	(none)	SE.7 SE.7 121599 SE.7	BXD w/par	24	m			2016

Dickson3:24	Dickson3	None	(none)	n.7 n.7 121600 n.7	BXD w/par	34	m			2016

Dickson3:25	Dickson3	None	(none)	COC_IVSA_INFUS_0.32 COC_IVSA_INFUS_0.32 121601 COC_IVSA_INFUS_0.32	BXD w/par	36	m			2016

Dickson3:26	Dickson3	None	(none)	SE.8 SE.8 121602 SE.8	BXD w/par	24	m			2016

Dickson3:27	Dickson3	None	(none)	n.8 n.8 121603 n.8	BXD w/par	36	m			2016

Dickson3:28	Dickson3	None	(none)	COC_IVSA_INFUS_0.56 COC_IVSA_INFUS_0.56 121604 COC_IVSA_INFUS_0.56	BXD w/par	23	m			2016

Dickson3:29	Dickson3	None	(none)	SE.9 SE.9 121605 SE.9	BXD w/par	13	m			2016

Dickson3:30	Dickson3	None	(none)	n.9 n.9 121606 n.9	BXD w/par	23	m			2016

Dickson3:31	Dickson3	None	(none)	COC_IVSA_INFUS_1.0 COC_IVSA_INFUS_1.0 121607 COC_IVSA_INFUS_1.0	BXD w/par	24	m			2016

Dickson3:32	Dickson3	None	(none)	SE.10 SE.10 121608 SE.10	BXD w/par	16	m			2016

Dickson3:33	Dickson3	None	(none)	n.10 n.10 121609 n.10	BXD w/par	24	m			2016

Dickson3:34	Dickson3	None	(none)	COC_IVSA_INFUS_1.8 COC_IVSA_INFUS_1.8 121610 COC_IVSA_INFUS_1.8	BXD w/par	25	m			2016

Dickson3:35	Dickson3	None	(none)	SE.11 SE.11 121611 SE.11	BXD w/par	16	m			2016

Dickson3:36	Dickson3	None	(none)	n.11 n.11 121612 n.11	BXD w/par	25	m			2016

Dickson3:37	Dickson3	None	(none)	COC_IVSA_ACTV_0.032 COC_IVSA_ACTV_0.032 121613 COC_IVSA_ACTV_0.032	BXD w/par	30	m			2016

Dickson3:38	Dickson3	None	(none)	SE.12 SE.12 121614 SE.12	BXD w/par	21	m			2016

Dickson3:39	Dickson3	None	(none)	n.12 n.12 121615 n.12	BXD w/par	30	m			2016

Dickson3:40	Dickson3	None	(none)	COC_IVSA_ACTV_0.056 COC_IVSA_ACTV_0.056 121616 COC_IVSA_ACTV_0.056	BXD w/par	26	m			2016

Dickson3:41	Dickson3	None	(none)	SE.13 SE.13 121617 SE.13	BXD w/par	21	m			2016

Dickson3:42	Dickson3	None	(none)	n.13 n.13 121618 n.13	BXD w/par	26	m			2016

Dickson3:43	Dickson3	None	(none)	COC_IVSA_ACTV_0.1 COC_IVSA_ACTV_0.1 121619 COC_IVSA_ACTV_0.1	BXD w/par	30	m			2016

Dickson3:44	Dickson3	None	(none)	SE.14 SE.14 121620 SE.14	BXD w/par	25	m			2016

Dickson3:45	Dickson3	None	(none)	n.14 n.14 121621 n.14	BXD w/par	30	m			2016

Dickson3:46	Dickson3	None	(none)	COC_IVSA_ACTV_0.18 COC_IVSA_ACTV_0.18 121622 COC_IVSA_ACTV_0.18	BXD w/par	24	m			2016

Dickson3:47	Dickson3	None	(none)	SE.15 SE.15 121623 SE.15	BXD w/par	20	m			2016

Dickson3:48	Dickson3	None	(none)	n.15 n.15 121624 n.15	BXD w/par	24	m			2016

Dickson3:49	Dickson3	None	(none)	COC_IVSA_ACTV_0.32 COC_IVSA_ACTV_0.32 121625	BXD w/par	23	m			2016

Dickson3:50	Dickson3	None	(none)	SE.16 SE.16 121626	BXD w/par	19	m			2016

Dickson3:51	Dickson3	None	(none)	n.16 n.16 121627	BXD w/par	23	m			2016

Dickson3:52	Dickson3	None	(none)	COC_IVSA_ACTV_0.56 COC_IVSA_ACTV_0.56 121628	BXD w/par	26	m			2016

Dickson3:53	Dickson3	None	(none)	SE.17 SE.17 121629	BXD w/par	13	m			2016

Dickson3:54	Dickson3	None	(none)	n.17 n.17 121630	BXD w/par	26	m			2016

Dickson3:55	Dickson3	None	(none)	COC_IVSA_ACTV_0.1.1 COC_IVSA_ACTV_0.1.1 121631	BXD w/par	26	m			2016

Dickson3:56	Dickson3	None	(none)	SE.18 SE.18 121632	BXD w/par	17	m			2016

Dickson3:57	Dickson3	None	(none)	n.18 n.18 121633	BXD w/par	26	m			2016

Dickson3:58	Dickson3	None	(none)	COC_IVSA_ACTV_1.8 COC_IVSA_ACTV_1.8 121634	BXD w/par	28	m			2016

Dickson3:59	Dickson3	None	(none)	SE.19 SE.19 121635	BXD w/par	17	m			2016

Dickson3:60	Dickson3	None	(none)	n.19 n.19 121636	BXD w/par	28	m			2016

Dickson3:61	Dickson3	None	(none)	COC_IVSA_INACTV_0.032 COC_IVSA_INACTV_0.032 121637	BXD w/par	33	m			2016

Dickson3:62	Dickson3	None	(none)	SE.20 SE.20 121638	BXD w/par	22	m			2016

Dickson3:63	Dickson3	None	(none)	n.20 n.20 121639	BXD w/par	33	m			2016

Dickson3:64	Dickson3	None	(none)	COC_IVSA_INACTV_0.056 COC_IVSA_INACTV_0.056 121640	BXD w/par	33	m			2016

Dickson3:65	Dickson3	None	(none)	SE.21 SE.21 121641	BXD w/par	23	m			2016

Dickson3:66	Dickson3	None	(none)	n.21 n.21 121642	BXD w/par	33	m			2016

Dickson3:67	Dickson3	None	(none)	COC_IVSA_INACTV_0.1 COC_IVSA_INACTV_0.1 121643	BXD w/par	36	m			2016

Dickson3:68	Dickson3	None	(none)	SE.22 SE.22 121644	BXD w/par	27	m			2016

Dickson3:69	Dickson3	None	(none)	n.22 n.22 121645	BXD w/par	36	m			2016

Dickson3:70	Dickson3	None	(none)	COC_IVSA_INACTV_0.18 COC_IVSA_INACTV_0.18 121646	BXD w/par	34	m			2016

Dickson3:71	Dickson3	None	(none)	SE.23 SE.23 121647	BXD w/par	24	m			2016

Dickson3:72	Dickson3	None	(none)	n.23 n.23 121648	BXD w/par	34	m			2016

Dickson3:73	Dickson3	None	(none)	COC_IVSA_INACTV_0.32 COC_IVSA_INACTV_0.32 121649	BXD w/par	36	m			2016

Dickson3:74	Dickson3	None	(none)	SE.24 SE.24 121650	BXD w/par	24	m			2016

Dickson3:75	Dickson3	None	(none)	n.24 n.24 121651	BXD w/par	36	m			2016

Dickson3:76	Dickson3	None	(none)	COC_IVSA_INACTV_0.56 COC_IVSA_INACTV_0.56 121652	BXD w/par	26	m			2016

Auwerx1

body weight

high-fat diet

body weight at 8 wks of age [g] bw_8wks 111180 CD HFD

BXD w/par

57

m

8wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 9 wks of age [g] bw_9wks 111182 CD HFD

BXD w/par

57

m

9wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 10 wks of age [g] bw_10wks 111184 CD HFD

BXD w/par

57

m

10wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 11 wks of age [g] bw_11wks 111186 CD HFD

BXD w/par

57

m

11wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 12 wks of age [g] bw_12wks 111188 CD HFD

BXD w/par

57

m

12wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 13 wks of age [g] bw_13wks 111190 CD HFD

BXD w/par

57

m

13wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 14 wks of age [g] bw_14wks 111192 CD HFD

BXD w/par

57

m

14wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 15 wks of age [g] bw_15wks 111194 CD HFD

BXD w/par

57

m

15wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 16 wks of age [g] bw_16wks 111196 CD HFD

BXD w/par

57

m

16wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 17 wks of age [g] bw_17wks 111198 CD HFD

BXD w/par

57

m

17wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 18 wks of age [g] bw_18wks 111200 CD HFD

BXD w/par

57

m

18wks

N=5

2016

Auwerx1

body weight

high-fat diet

body weight at 19 wks of age [g] bw_19wks 111202 CD High fat diet

BXD w/par

57

m

19wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 20 wks of age [g] bw_20wks 111204 CD HFD

BXD w/par

55

m

20wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 21 wks of age [g] bw_21wks 111206 CD HFD

BXD w/par

56

m

21wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 22 wks of age [g] bw_22wks 111208 CD HFD

BXD w/par

57

m

22wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 23 wks of age [g] bw_23wks 111210 CD HFD

BXD w/par

56

m

23wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 24 wks of age [g] bw_24wks 111212 CD HFD

BXD w/par

26

m

24wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 25 wks of age [g] bw_25wks 111214 CD HFD

BXD w/par

49

m

25wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 26 wks of age [g] bw_26wks 111216 CD HFD

BXD w/par

53

m

26wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 27 wks of age [g] bw_27wks 111218 CD HFD

BXD w/par

57

m

27wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at 28 wks of age [g] bw_28wks 111220 CD HFD

BXD w/par

57

m

28wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at pre-sacrifice, 29 wks of age [g] bw_presac 111222 CD HFD

BXD w/par

55

m

29wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight at sacrifice, 29 wks of age [g] bw_sac 111224 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight prior to respiration test, 16 wks of age [g] bw_resp 111226 CD HFD

BXD w/par

57

m

16wks

N=4

2016

Auwerx1

NMR

high-fat diet

fat tissue mass, 16 wks of age [g] ftm_16wks 111228 CD HFD

BXD w/par

57

m

16wks

N=4

2016

Auwerx1

NMR

high-fat diet

lean tissue mass, 16 wks of age [g] ltm_16wks 111230 CD HFD

BXD w/par

57

m

16wks

N=4

2016

Auwerx1

intake monitoring

high-fat diet

food_intake_16wks [g/day] food_intake_16wks 111232 CD HFD

BXD w/par

45

m

16wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

respiratory exchange rate (VCO2:VO2), 24h test, during day [ratio] rer_day 111234 CD HFD

BXD w/par

53

m

16wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

respiratory exchange rate (VCO2:VO2), 24h test, during night [ratio] rer_night 111236 CD HFD

BXD w/par

53

m

16wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

oxygen consumption, 24h period, during day [mL/kg/min] vo2_day 111238 CD HFD

BXD w/par

53

m

16wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

oxygen consumption, 24h period, during night [mL/kg/min] vo2_night 111240 CD HFD

BXD w/par

53

m

16wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight prior to oral glucose tolerance test (OGTT), 17 wks of age [g] bw_ogtt 111242 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose baseline, glucose tolerance test (pregavage, overnight fast) [mg/dL] ogtt_gluc_t0 111244 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [mg/dL] ogtt_gluc_t15 111246 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [mg/dL] ogtt_gluc_t30 111248 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 45 min [mg/dL] ogtt_gluc_t45 111250 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 60 min [mg/dL] ogtt_gluc_t60 111252 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 90 min [mg/dL] ogtt_gluc_t90 111254 CD HFD

BXD w/par

55

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 120 min [mg/dL] ogtt_gluc_t120 111256 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 150 min [mg/dL] ogtt_gluc_t150 111258 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, glucose tolerance test (20% glucose oral gavage, overnight fast), after 180 min [mg/dL] ogtt_gluc_t180 111260 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

glucose tolerance

high-fat diet

glucose, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_gluc_auc 111262 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin baseline, glucose tolerance test (pregavage, overnight fast) [µg/L] ogtt_ins_t0 111264 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 15 min [µg/L] ogtt_ins_t15 111266 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin, glucose tolerance test (20% glucose oral gavage, overnight fast), after 30 min [µg/L] ogtt_ins_t30 111268 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

hormone quantification

high-fat diet

insulin, area under curve, glucose tolerance test (20% glucose oral gavage, overnight fast) [AUC] ogtt_ins_auc 111270 CD HFD

BXD w/par

57

m

17wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight prior to non-invasive blood pressure, 19 wks of age [g] bw_bp 111272 CD HFD

BXD w/par

55

m

19wks

N=4

2016

Auwerx1

tail cuff

high-fat diet

systolic blood pressure [mmHg] systolic_bp 111274 CD HFD

BXD w/par

57

m

19wks

N=4

2016

Auwerx1

tail cuff

high-fat diet

diastolic blood pressure [mmHg] diastolic_bp 111276 CD HFD

BXD w/par

57

m

19wks

N=4

2016

Auwerx1

tail cuff

high-fat diet

heart rate [n/min] hr 111278 CD HFD

BXD w/par

56

m

19wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight prior to cold response test, 21 wks of age [g] bw_coldtest 111280 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 0h exposed to cold [°C] temp_t0 111282 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 1h exposed to cold [°C] temp_t1 111284 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 2h exposed to cold [°C] temp_t2 111286 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 3h exposed to cold [°C] temp_t3 111288 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 4h exposed to cold [°C] temp_t4 111290 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 5h exposed to cold [°C] temp_t5 111292 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

body temperature

high-fat diet

body temperature (rectal) in cold (4°C) room, 6h exposed to cold [°C] temp_t6 111294 CD HFD

BXD w/par

57

m

21wks

N=4

2016

Auwerx1

NMR

high-fat diet

fat tissue mass, 23 wks of age [g] ftm_23wks 111296 CD HFD

BXD w/par

52

m

23wks

N=4

2016

Auwerx1

NMR

high-fat diet

lean tissue mass, 23 wks of age [g] ltm_23wks 111298 CD HFD

BXD w/par

52

m

23wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight prior to basal activity test, at 23 wks of age [g] bw_basal 111300 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

intake monitoring

high-fat diet

daily food intake, basal activity test, for 2 days, 23 wks of age [g/day] food_intake_23wks 111302 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

horizontal activity (beam breaks) at night, basal activity test, for 48h [n/h] horiz_act 111304 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

vertical activity (beam breaks) at night, basal activity test, for 48h [n/h] vert_act 111306 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

basal oxygen consumption, prior to first treadmill training [mL/kg/min] vo2_basal 111308 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

basal respiratory exchange ratio (RER), prior to first treadmill training (VCO2:VO2), 15 min time period, last 2 min analyzed [ratio] rer_basal 111310 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight, prior to first treadmill training [g] bw_treadmill1 111312 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

maximum oxygen consumption, first treadmill training [mL/kg/min] vo2_max_treadmill1 111314 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

treadmill endurance test

high-fat diet

distance traveled, first treadmill training [m] dist_treadmill1 111316 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

maximum respiratory exchange ratio (RER), first treadmill training (VCO2:VO2) [ratio] rer_max_treadmill1 111318 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

running wheel monitoring

high-fat diet

distance traveled, voluntary wheel running test, last 24h [km] dist_wheel 111320 CD HFD

BXD w/par

57

m

23wks

N=4

2016

Auwerx1

running wheel monitoring

high-fat diet

speed (mean rpm), voluntary wheel running test, 24h [n/min] speed_wheel 111322 CD HFD

BXD w/par

36

m

23wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

basal oxygen consumption, after voluntary wheel running test [mL/kg/min] vo2_basal_wheel 111324 CD HFD

BXD w/par

57

m

25wks

N=4

2016

Auwerx1

NMR

high-fat diet

fat tissue mass, 25 wks of age [g] ftm_25wks 111326 CD HFD

BXD w/par

53

m

25wks

N=4

2016

Auwerx1

NMR

high-fat diet

lean tissue mass, 25 wks of age [g] ltm_25wks 111328 CD HFD

BXD w/par

53

m

25wks

N=4

2016

Auwerx1

body weight

high-fat diet

body weight, prior to second treadmill training, at 25 wks of age [g] bw_treadmill2 111330 CD HFD

BXD w/par

57

m

25wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

maximum oxygen consumption, second treadmill training [mL/kg/min] vo2_max_treadmill2 111332 CD HFD

BXD w/par

57

m

25wks

N=4

2016

Auwerx1

treadmill endurance test

high-fat diet

distance traveled, second treadmill training [m] dist_treadmill2 111334 CD HFD

BXD w/par

57

m

25wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

basal respiratory exchange ratio (RER), second treadmill training (VCO2:VO2) [ratio] rer_basal_treadmill2 111336 CD HFD

BXD w/par

57

m

25wks

N=4

2016

Auwerx1

monitoring system

high-fat diet

maximum respiratory exchange ratio (RER), second treadmill test (VCO2:VO2) [ratio] rer_max_treadmill2 111338 CD HFD

BXD w/par

57

m

25wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood alanine transaminase amount [U/L] ala_trans 111340 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood alkaline phosphatase amount [U/L] alk_phosph 111342 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood amylase amount [U/L] amylase 111344 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood aspartate transaminase amount [U/L] asp_trans 111346 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood bile acid amount [µmol/L] bile 111348 CD HFD

BXD w/par

38

m

29wks

N=3

2016

Auwerx1

metabolic panel

high-fat diet

blood creatine kinase amount [U/L] creatine_kin 111350 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood creatinine amount [µmol/L] creatinine 111352 CD HFD

BXD w/par

47

m

29wks

N=4

2016

Auwerx1

lipid profile

high-fat diet

blood free fatty acids amount [mmol/L] fatty_acids 111354 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood glucose amount [mmol/L] glu 111356 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

lipid profile

high-fat diet

blood HDL amount [mmol/L] hdl 111358 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood iron amount [µmol/L] iron 111360 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood lactate amount [mmol/L] lactate 111362 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

blood lactate dehydrogenase (LDH) amount [U/L] ldh 111364 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

lipid profile

high-fat diet

blood LDL amount [mmol/L] ldl 111366 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

metabolic panel

high-fat diet

total blood protein amount [g/L] protein 111368 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

lipid profile

high-fat diet

blood total cholesterol amount [mmol/L] chol_tot 111370 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

lipid profile

high-fat diet

blood triglyceride amount [mmol/L] triglyc 111372 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood interferon gamma (INF gamma) amount [pg/mL] inf_gamma 111374 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood interleukin-18 (IL-18) amount [pg/mL] il_18 111376 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood interleukin-6 (IL-6) amount [pg/mL] il_6 111378 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood interleukin-10 (IL-10) amount [pg/mL] il_10 111380 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood interleukin-15 (IL-15) amount [pg/mL] il_15 111382 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood monocyte chemoattractant protein 1 (MCP1) amount [pg/mL] mcp1 111384 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood macrophage inflammatory protein 1 alpha subunit (MIP1 alpha) amount [pg/mL] mip1_alpha 111386 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood macrophage inflammatory protein 1 beta subunit (MIP1 beta) amount [pg/mL] mip1_beta 111388 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood regulated on activation, normal T cell expressed and secreted (RANTES) protein amount [pg/mL] rantes 111390 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

cell signaling molecule detection

high-fat diet

blood tumor necrosis factor alpha (TNF alpha) amount [pg/mL] tnf_alpha 111392 CD HFD

BXD w/par

33

m

29wks

N=4

2016

Auwerx1

complete blood count

high-fat diet

hematocrit (HCT) [%] hct 111394 CD HFD

BXD w/par

31

m

29wks

N=4

2016

Auwerx1

complete blood count

high-fat diet

red blood cell count (RBC; per volume x 10⁶) [n/µL] rbc 111396 CD HFD

BXD w/par

31

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

epididymal fat pad weight [g] epid_fat_wt 111398 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

skeletal muscle weight [g] muscle_wt 111400 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

heart weight [g] heart_wt 111402 CD HFD

BXD w/par

56

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

kidney weight (both) [g] kidney_wt 111404 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

liver weight [g] liver_wt 111406 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

perirenal white adipose tissue [g] perirenal_wt 111408 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

subcutaneous adipose tissue weight [g] subcut_adip_wt 111410 CD HFD

BXD w/par

54

m

29wks

N=4

2016

Auwerx1

organ weights

high-fat diet

soleus muscle weight [g] soleus_wt 111412 CD HFD

BXD w/par

57

m

29wks

N=4

2016

Chesler1

nociception assay

(none)

latency of nociception to mechanical pressure on the tail [s] TC 34801

BXD

61

both

7-15wks

N=7

2010

Chesler1

nociception assay

(none)

mean sensory threshold eliciting withdrawal response from both hindfeet, Von Frey test days 1 and 2 [mN] VF 34810

BXD

61

both

7-15wks

N=6

2010

Chesler1

nociception assay

(none)

mean latency of both hindpaws to withdraw, Hargreaves test trials 1-3 [s] mean_HT 34819

BXD

61

both

7-15wks

N=6

2010

Chesler1

nociception assay

(none)

mean latency of tail withdrawal to thermal stimulation (trials 1, 2, 3) [s] mean_TW 34823

BXD

61

both

7-15wks

N=7

2010

Chesler1

nociception assay

(none)

mean latency of nociceptive response to hot plate (transformed) [s] mean_logN_HP 34829

BXD

61

both

7-15wks

N=6

2010

Crusio1

body weight

(none)

body weight [g] bw 62001

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

open field test

(none)

percentage of total time spent in center, 20 min test [%] center_time 62003

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

distance run in center, 20 min test [cm] center_dist 62004

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

percentage of total time spent in thigmotaxis zone, 20 min test [%] periphery_time 62005

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

distance run in thigmotaxis zone, 20 min test [cm] periphery_dist 62006

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

percentage of total distance run in thigmotaxis zone, 20 min test [%] periphery_dist_pct 62007

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

total locomotor activity, 20 min test [cm] activity 62008

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

number of leanings against wall, 20 min test [n] lean 62009

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

number of rearings, forepaws not resting against wall, 20 min test [n] rear 62010

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

number of jumps (all 4 paws leave floor), 20 min test [n] jump 62011

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

number of fecal boli deposited, 20 min test [n] defec 62012

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

frequency of bouts of grooming, 20 min test [n] groom_freq 62013

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

total duration of grooming, 20 min test [s] groom_dur 62014

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

open field test

(none)

mean duration of grooming bouts, 20 min test [s] groom_bout 62015

BXD w/par

55

both

10-12wks

N=8

2018

Crusio1

radial maze

(none)

time to complete task [s] task_time 62016 day 1 day 2 day 3 day 4 day 5

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

number of different arms visited during first 8 arm choices of a trial [n] num_arms 62021 day 1 day 2 day 3 day 4 day 5

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

number of different arms visited during first 8 arm choices of a trial minus 5.3 (number expected by chance) [n] num_arms_adj 62026 day 3 day 4 day 5 mean

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

number of errors made before all 8 rewards collected [n] errors 62030 day 1 day 2 day 3 day 4 day 5 sum of days 3 4 5

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

radial maze

(none)

mean duration per arm visit (including errors) [s] visit_time 62036 day 3 day 4 day 5 mean

BXD w/par

55

both

10-13wks

N=8

2018

Crusio1

behavior observation

(none)

attack latency [s] latency 62040 day 1 day 2

BXD w/par

55

m

12-16wks

N=8

2018

Crusio1

behavior observation

(none)

whether an animal attacks (0=no, 1=yes) [score] attack 62042 day 1 day 2

BXD w/par

55

m

12-16wks

N=8

2018

Crusio1

behavior observation

(none)

whether an animal attacks (0=not either day, 1=yes on one or both days) [score] attack_combine 62044

BXD w/par

54

m

12-16wks

N=8

2018

Crusio1

organ weights

(none)

brain weight [g] brain_wt 62045

BXD w/par

55

both

12-16wks

N=8

2018

Crusio1

organ weights

(none)

brain weight as percentage of total body weight [%] brain_wt_pct 62046

BXD w/par

55

both

12-16wks

N=8

2018

Crusio1

histopathology

(none)

total hippocampus size (arbitrary units) hippocampus 62048 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of intra- and infrapyramidal mossy fibers (arbitrary units) iipmf 62050 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is Intra- and infrapyramidal mossy fibers [%] iipmf_pct 62052 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of hilus (arbitrary units) hilus 62055 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is hilus [%] hilus_pct 62057 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of suprapyramidal mossy fibers (arbitrary units) supra 62060 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is suprapyramidal mossy fibers [%] supra_pct 62062 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of stratum pyramidale (arbitrary units) pyr 62065 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is stratum pyramidale [%] pyr_pct 62067 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of stratum oriens (arbitrary units) oriens 62070 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is stratum oriens [%] oriens_pct 62072 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of stratum radiatum (arbitrary units) rad 62075 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is stratum radiatum [%] rad_pct 62077 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

size of stratum lacunosum-moleculare (arbitrary units) lacun 62080 left right

BXD w/par

55

both

12-16wks

N=4

2018

Crusio1

histopathology

(none)

percentage of hippocampus that is stratum lacunosum-moleculare [%] lacun_pct 62082 left right mean

BXD w/par

55

both

12-16wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

fixed ratio 1 (FR1), active lever presses, 8 h test [n] FR1active 60201 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

fixed ratio 1 (FR1), lever press rate, 8 h test [n/s] FR1rate 60206 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

variable ratio 2 (VR2), active lever presses, 8 h test [n] VR2active 60211 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

variable ratio 2 (VR2), lever press rate, 8 h test [n] VR2rate 60216 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

variable ratio 5 (VR5), active lever presses, 8 h test [n] VR5active 60221 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

variable ratio 5 (VR5), lever press rate, 8 h test [n/s] VR5rate 60226 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

active lever presses, 8 h test [n] Actives 60231 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

reinforcers earned, 8 h test [n] Reinfs 60241 day 1 day 2 day 3 across 3 days

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

time elapsed before first reinforcer earned, 8 h test [s] FirstReinf 60251

HMDP

91

m

7-22wks

N=4

2018

CSNA01

operant conditioning chamber

sucrose

time elapsed between earning first and fiftieth reinforcer, 8 h test [s] Time1to50 60252

HMDP

82

m

7-22wks

N=3

2018

CSNA01

operant conditioning chamber

sucrose

whether criterion of 50 reinforcers earned was met, 8 h test (1=yes, 0=no) [score] Learned 60253

HMDP

91

m

7-22wks

N=4

2018

CSNA01

body weight

(none)

body weight prior to testing [g] bw_pre 60261

HMDP

85

m

7-22wks

N=4

2018

CSNA01

body weight

sucrose

percentage of starting body weight [%] bw 60271 day 1 before day 1 after day 2 before day 2 after day 3 before day 3 after (2 more)...

HMDP

84

m

7-22wks

N=4

2018

Dickson3

None

(none)

COC_IVSA_SES_TO_ACQ COC_IVSA_SES_TO_ACQ 121577

BXD w/par

26

m

2016

Dickson3

None

(none)

SE SE 121578

BXD w/par

13

m

2016

Dickson3

None

(none)

n n 121579

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_IDL COC_IVSA_IDL 121580

BXD w/par

26

m

2016

Dickson3

None

(none)

SE.1 SE.1 121581

BXD w/par

13

m

2016

Dickson3

None

(none)

n.1 n.1 121582

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_IAL COC_IVSA_IAL 121583

BXD w/par

26

m

2016

Dickson3

None

(none)

SE.2 SE.2 121584

BXD w/par

17

m

2016

Dickson3

None

(none)

n.2 n.2 121585

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_CAL COC_IVSA_CAL 121586

BXD w/par

28

m

2016

Dickson3

None

(none)

SE.3 SE.3 121587

BXD w/par

17

m

2016

Dickson3

None

(none)

n.3 n.3 121588

BXD w/par

28

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_0.032 COC_IVSA_INFUS_0.032 121589 COC_IVSA_INFUS_0.032

BXD w/par

33

m

2016

Dickson3

None

(none)

SE.4 SE.4 121590 SE.4

BXD w/par

22

m

2016

Dickson3

None

(none)

n.4 n.4 121591 n.4

BXD w/par

33

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_0.056 COC_IVSA_INFUS_0.056 121592 COC_IVSA_INFUS_0.056

BXD w/par

33

m

2016

Dickson3

None

(none)

SE.5 SE.5 121593 SE.5

BXD w/par

23

m

2016

Dickson3

None

(none)

n.5 n.5 121594 n.5

BXD w/par

33

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_0.1 COC_IVSA_INFUS_0.1 121595 COC_IVSA_INFUS_0.1

BXD w/par

36

m

2016

Dickson3

None

(none)

SE.6 SE.6 121596 SE.6

BXD w/par

27

m

2016

Dickson3

None

(none)

n.6 n.6 121597 n.6

BXD w/par

36

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_0.18 COC_IVSA_INFUS_0.18 121598 COC_IVSA_INFUS_0.18

BXD w/par

34

m

2016

Dickson3

None

(none)

SE.7 SE.7 121599 SE.7

BXD w/par

24

m

2016

Dickson3

None

(none)

n.7 n.7 121600 n.7

BXD w/par

34

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_0.32 COC_IVSA_INFUS_0.32 121601 COC_IVSA_INFUS_0.32

BXD w/par

36

m

2016

Dickson3

None

(none)

SE.8 SE.8 121602 SE.8

BXD w/par

24

m

2016

Dickson3

None

(none)

n.8 n.8 121603 n.8

BXD w/par

36

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_0.56 COC_IVSA_INFUS_0.56 121604 COC_IVSA_INFUS_0.56

BXD w/par

23

m

2016

Dickson3

None

(none)

SE.9 SE.9 121605 SE.9

BXD w/par

13

m

2016

Dickson3

None

(none)

n.9 n.9 121606 n.9

BXD w/par

23

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_1.0 COC_IVSA_INFUS_1.0 121607 COC_IVSA_INFUS_1.0

BXD w/par

24

m

2016

Dickson3

None

(none)

SE.10 SE.10 121608 SE.10

BXD w/par

16

m

2016

Dickson3

None

(none)

n.10 n.10 121609 n.10

BXD w/par

24

m

2016

Dickson3

None

(none)

COC_IVSA_INFUS_1.8 COC_IVSA_INFUS_1.8 121610 COC_IVSA_INFUS_1.8

BXD w/par

25

m

2016

Dickson3

None

(none)

SE.11 SE.11 121611 SE.11

BXD w/par

16

m

2016

Dickson3

None

(none)

n.11 n.11 121612 n.11

BXD w/par

25

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.032 COC_IVSA_ACTV_0.032 121613 COC_IVSA_ACTV_0.032

BXD w/par

30

m

2016

Dickson3

None

(none)

SE.12 SE.12 121614 SE.12

BXD w/par

21

m

2016

Dickson3

None

(none)

n.12 n.12 121615 n.12

BXD w/par

30

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.056 COC_IVSA_ACTV_0.056 121616 COC_IVSA_ACTV_0.056

BXD w/par

26

m

2016

Dickson3

None

(none)

SE.13 SE.13 121617 SE.13

BXD w/par

21

m

2016

Dickson3

None

(none)

n.13 n.13 121618 n.13

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.1 COC_IVSA_ACTV_0.1 121619 COC_IVSA_ACTV_0.1

BXD w/par

30

m

2016

Dickson3

None

(none)

SE.14 SE.14 121620 SE.14

BXD w/par

25

m

2016

Dickson3

None

(none)

n.14 n.14 121621 n.14

BXD w/par

30

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.18 COC_IVSA_ACTV_0.18 121622 COC_IVSA_ACTV_0.18

BXD w/par

24

m

2016

Dickson3

None

(none)

SE.15 SE.15 121623 SE.15

BXD w/par

20

m

2016

Dickson3

None

(none)

n.15 n.15 121624 n.15

BXD w/par

24

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.32 COC_IVSA_ACTV_0.32 121625

BXD w/par

23

m

2016

Dickson3

None

(none)

SE.16 SE.16 121626

BXD w/par

19

m

2016

Dickson3

None

(none)

n.16 n.16 121627

BXD w/par

23

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.56 COC_IVSA_ACTV_0.56 121628

BXD w/par

26

m

2016

Dickson3

None

(none)

SE.17 SE.17 121629

BXD w/par

13

m

2016

Dickson3

None

(none)

n.17 n.17 121630

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_0.1.1 COC_IVSA_ACTV_0.1.1 121631

BXD w/par

26

m

2016

Dickson3

None

(none)

SE.18 SE.18 121632

BXD w/par

17

m

2016

Dickson3

None

(none)

n.18 n.18 121633

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_ACTV_1.8 COC_IVSA_ACTV_1.8 121634

BXD w/par

28

m

2016

Dickson3

None

(none)

SE.19 SE.19 121635

BXD w/par

17

m

2016

Dickson3

None

(none)

n.19 n.19 121636

BXD w/par

28

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_0.032 COC_IVSA_INACTV_0.032 121637

BXD w/par

33

m

2016

Dickson3

None

(none)

SE.20 SE.20 121638

BXD w/par

22

m

2016

Dickson3

None

(none)

n.20 n.20 121639

BXD w/par

33

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_0.056 COC_IVSA_INACTV_0.056 121640

BXD w/par

33

m

2016

Dickson3

None

(none)

SE.21 SE.21 121641

BXD w/par

23

m

2016

Dickson3

None

(none)

n.21 n.21 121642

BXD w/par

33

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_0.1 COC_IVSA_INACTV_0.1 121643

BXD w/par

36

m

2016

Dickson3

None

(none)

SE.22 SE.22 121644

BXD w/par

27

m

2016

Dickson3

None

(none)

n.22 n.22 121645

BXD w/par

36

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_0.18 COC_IVSA_INACTV_0.18 121646

BXD w/par

34

m

2016

Dickson3

None

(none)

SE.23 SE.23 121647

BXD w/par

24

m

2016

Dickson3

None

(none)

n.23 n.23 121648

BXD w/par

34

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_0.32 COC_IVSA_INACTV_0.32 121649

BXD w/par

36

m

2016

Dickson3

None

(none)

SE.24 SE.24 121650

BXD w/par

24

m

2016

Dickson3

None

(none)

n.24 n.24 121651

BXD w/par

36

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_0.56 COC_IVSA_INACTV_0.56 121652

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_1.0 COC_IVSA_INACTV_1.0 121653

BXD w/par

26

m

2016

Dickson3

None

(none)

COC_IVSA_INACTV_1.8 COC_IVSA_INACTV_1.8 121654

BXD w/par

36

m

2016

Dickson3

None

(none)

SE.27 SE.27 121655

BXD w/par

24

m

2016

Dickson3

None

(none)

n.27 n.27 121656

BXD w/par

36

m

2016

DiCurzio1

body weight

(none)

body weight at testing [g] bw 36601

BXD w/par

66

both

7-10wks*

N=4

2010

DiCurzio1

organ weights

(none)

adrenal weights [mg] adr_wt 36602 left right

BXD w/par

66

both

7-10wks*

N=4

2010

DiCurzio1

organ weights

(none)

mean weight of both adrenals [mg] adr_wt_ave 36604

BXD w/par

66

both

7-10wks*

N=4

2010

DiCurzio1

organ weights

(none)

total weight of adrenals adjusted to body weight (x10^-3) [mg] adr_adj_bw 36605

BXD w/par

66

both

7-10wks*

N=4

2010

DiCurzio1

histopathology

(none)

adrenal total width, diameter [µm] adr_width 36606

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal medulla width [µm] adr_medul_width 36607

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal cortex zona glomerulosa thickness [µm] adr_glome_width 36608

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal cortex zona intermedia thickness [µm] adr_inter_width 36609

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal cortex zona fasciculata thickness [µm] adr_fasci_width 36610

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal cortex zona reticularis thickness [µm] adr_retic_width 36611

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal cortex X-zone thickness [µm] adr_Xzone_width 36612

BXD w/par

66

both

7-10wks*

N=3

2010

DiCurzio1

histopathology

(none)

adrenal glands, presence of X-zone (0=no; 1=yes) [score] Xzone_presence 36614

BXD w/par

66

both

7-10wks*

N=4

2010

DiCurzio1

histopathology

(none)

adrenal glands, presence of lipoid structures in females (0=none; 1=outside X-zone; 2=within X-zone) [score] lipoid_presence 36615

BXD w/par

66

f

7-10wks*

N=4

2010

DiCurzio1

colony observation

(none)

age at testing (local parameter) [wks] age 36680

BXD w/par

66

both

N=4

2010

Donahue14

colony observation

(none)

mean litter interval [wks] litter_interval 42302

BXD

40

f

3-60wks

N=4

2011

Donahue14

colony observation

(none)

mean number of pups born [n] litter_size_birth 42303

BXD

42

f

3-60wks

N=6

2011

Donahue14

colony observation

(none)

mean number of pups weaned [n] litter_size_wean 42304

BXD

42

f

3-60wks

N=6

2011

Donahue14

colony observation

(none)

ratio of pups weaned to pups born [ratio] ratio_wean_born 42305

BXD

42

f

3-60wks

N=6

2011

Donahue14

colony observation

(none)

mean litter size divided by mean litter interval [n/wks] fecundity_index 42306

BXD

40

f

3-60wks

N=4

2011

Donahue14

colony observation

(none)

percent females at weaning [%] pct_Fwean 42307

BXD

42

f

3-60wks

N=6

2011

Donahue17

colony observation

(none)

mean litter interval [wks] litter_interval 44301

BXD

30

f

3-57wks

N=8

2011

Donahue17

colony observation

(none)

mean number of pups born [n] litter_size_birth 44302

BXD

30

f

3-57wks

N=8

2011

Donahue17

colony observation

(none)

mean number of pups weaned [n] litter_size_wean 44303

BXD

30

f

3-57wks

N=8

2011

Donahue17

colony observation

(none)

ratio of pups weaned to pups born [ratio] ratio_wean_born 44304

BXD

30

f

3-57wks

N=8

2011

Donahue17

colony observation

(none)

mean litter size divided by mean litter interval [n/wks] fecundity_index 44305

BXD

30

f

3-57wks

N=8

2011

Donahue17

colony observation

(none)

percent females at weaning [%] pct_Fwean 44306

BXD

30

f

3-57wks

N=8

2011

HMDPpheno1

DXA

(none)

whole body bone mineral density (BMD; skull, lumbar spine, left femur excluded) [g/cm²] BMD_body 44601

HMDP w/par

96

m

16wks

N=9

2011

HMDPpheno1

DXA

(none)

bone mineral density (BMD) of left femur [g/cm²] BMD_femur 44602

HMDP w/par

96

m

16wks

N=9

2011

HMDPpheno1

DXA

(none)

bone mineral density (BMD) of lumbar spine [g/cm²] BMD_spine 44603

HMDP w/par

96

m

16wks

N=9

2011

HMDPpheno10

metabolite quantification

(none)

liver methylphosphate (16h fast), relative abundance methylphosphate 50501

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver xanthine (16h fast), relative abundance xanthine 50502

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver xanthosine (16h fast), relative abundance xanthosine 50503

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver 2'-deoxyinosine (16h fast), relative abundance deoxyinosine 50504

HMDP

105

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

hypoxanthine (16h fast), relative abundance hypoxanthine 50505

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

inosine (16h fast), relative abundance inosine 50506

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

adenine (16h fast), relative abundance adenine 50507

HMDP

105

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

adenosine (16h fast), relative abundance adenosine 50508

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver adenosine 2'-monophosphate (2'-AMP) (16h fast), relative abundance AMP_2 50509

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver adenosine 3'-monophosphate (3'-AMP) (16h fast), relative abundance AMP_3 50510

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver adenosine 5'-monophosphate (AMP) (16h fast), relative abundance AMP_5 50511

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver N1-methyladenosine (16h fast), relative abundance methyladenosine 50512

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver guanosine (16h fast), relative abundance guanosine 50513

HMDP

99

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver allantoin (16h fast), relative abundance allantoin 50514

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

liver cytidine 5'-monophosphate (5'-CMP) (16h fast), relative abundance CMP_5 50515

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

cytidine (16h fast), relative abundance cytidine 50516

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

thymine (16h fast), relative abundance thymine 50517

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

3-aminoisobutyrate (16h fast), relative abundance aminoisobutyrate 50518

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

uracil (16h fast), relative abundance uracil 50519

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

5-methyluridine (ribothymidine) (16h fast), relative abundance methyluridine 50520

HMDP

100

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

pseudouridine (16h fast), relative abundance pseudouridine 50521

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

uridine (16h fast), relative abundance uridine 50522

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

glycylglycine (16h fast), relative abundance glycylglycine 50523

HMDP

102

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

glycylisoleucine (16h fast), relative abundance glycylisoleucine 50524

HMDP

92

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

glycylleucine (16h fast), relative abundance glycylleucine 50525

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

glycylproline (16h fast), relative abundance glycylproline 50526

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

glycylvaline (16h fast), relative abundance glycylvaline 50527

HMDP

105

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

gamma-glutamylglutamate (16h fast), relative abundance GGG 50528

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

gamma-glutamylisoleucine (16h fast), relative abundance GGI 50529

HMDP

95

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

gamma-glutamylleucine (16h fast), relative abundance GGL 50530

HMDP

106

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

gamma-glutamylthreonine (16h fast), relative abundance GGT 50531

HMDP

104

m

16wks

N=1

2014

HMDPpheno10

metabolite quantification

(none)

gamma-glutamylvaline (16h fast), relative abundance GGV 50532

HMDP

106

m

16wks

N=1

2014

HMDPpheno11

histopathology

high-fat high-cholesterol diet

aortic lesion size (area) [µm²] aortic_lesion 110077

HMDP hAPOE and hCETP transgenic

103

both

23-25wks

N=5

2015

HMDPpheno2

lipid profile

(none)

HDL cholesterol (plasma HDL) [mg/dL] HDL 46401

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno2

lipid profile

(none)

low density lipoprotein (plasma LDL) plus very low density lipoprotein (plasma VLDL) [mg/dL] LDL_VLDL 46402

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno2

lipid profile

(none)

unesterified cholesterol (plasma CHOL) [mg/dL] CHOL_un 46403

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno2

lipid profile

(none)

total cholesterol (plasma CHOL) [mg/dL] CHOL_tot 46404

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno2

lipid profile

(none)

free fatty acids (plasma FFA) [mEq/L] FFA 46405

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno2

lipid profile

(none)

triglycerides (plasma TG, 16h fast) [mg/dL] TG 46406

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno2

NMR

(none)

percentage of tissue mass that is fat, whole body with head (NMR) [%] pct_fat 46407

HMDP w/par

99

m

16wks

N=7

2010

HMDPpheno3

tail cuff

(none)

pulse rate [n/min] HR 45301

HMDP w/par

58

m

9-10wks

N=6

2012

HMDPpheno3

tail cuff

(none)

systolic blood pressure [mmHg] BP 45302

HMDP w/par

58

m

9-10wks

N=6

2012

HMDPpheno4

fear conditioning test

(none)

fear training, percent time spent near chamber walls, day1 [%] ftr_thig 46801 pre-stimulus post-stimulus

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

fear training, velocity, day 1 [cm/s] ftr_vel 46811 pre-stimulus post-stimulus

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

fear training, percent time immobile, day 1 [%] ftr_imob 46821 pre-stimulus post-stimulus

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

fear training activity burst to footshock, shock reactivity, day 1 [cm/s] ftr_post_act_burst 46831

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

contextual fear thigmotaxis, percent time spent near chamber walls, day 2 [%] ctx_thig 46836

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

contextual fear velocity, day 2 [cm/s] ctx_vel 46841

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

contextual fear percent time immobile, day 2 [%] ctx_imob 46846

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

cued fear thigmotaxis, percent time spent near chamber walls, day 3 [%] thig 46851 pre-cue cue

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

cued fear, velocity, day 3 [cm/s] vel 46861 pre-cue cue

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

cued fear, percent time immobile, day 3 [%] imob 46871 pre-cue cue

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno5

complete blood count

(none)

white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 48901

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 48907

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 48913

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

monocyte count (MONO; units per volume x 10³) [n/µL] MONO 48919

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 48925

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 48931

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 48937

HMDP w/par

79

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

red blood cell count (RBC; units per volume x 10⁶) [n/µL] RBC 48943

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 48949

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 48955

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

mean RBC corpuscular hemoglobin (MCH) [pg] MCH 48961

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 48967

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

hemoglobin (HGB) [g/dL] HGB 48973

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

hematocrit (HCT) [%] HCT 48979

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] PLT 48985

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno5

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 48991

HMDP w/par

83

m

16wks

N=3

2013

HMDPpheno6

metabolite quantification

(none)

liver alanine (16h fast), relative abundance Ala 50101

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver asparagine (16h fast), relative abundance Asn 50102

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver aspartate (16h fast), relative abundance Asp 50103

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver beta-alanine (16h fast), relative abundance beta_Ala 50104

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N-acetylasparagine (16h fast), relative abundance acetyl_Asn 50105

HMDP w/par

103

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N-acetylalanine (16h fast), relative abundance acetyl_Ala 50106

HMDP w/par

104

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 2-aminobutyrate (16h fast), relative abundance aminobutyrate 50107

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver creatine (16h fast), relative abundance creatine 50108

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 2-hydroxybutyrate (AHB) (16h fast), relative abundance AHB 50109

HMDP w/par

99

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver cysteine (16h fast), relative abundance Cys 50110

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver hypotaurine (16h fast), relative abundance hypotaurine 50111

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver methionine (16h fast), relative abundance Met 50112

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver methionine sulfoxide (16h fast), relative abundance Met_sulf 50113

HMDP w/par

104

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver taurine (16h fast), relative abundance taurine 50114

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N-acetylmethionine (16h fast), relative abundance acetyl_Met 50115

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver S-adenosylhomocysteine (SAH) (16h fast), relative abundance SAH 50116

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver gamma-aminobutyrate (GABA) (16h fast), relative abundance GABA 50117

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N-acetylglutamate (16h fast), relative abundance acetyl_Glu 50118

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glutamine (16h fast), relative abundance Gln 50119

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glutamate (16h fast), relative abundance Glu 50120

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver cysteine-glutathione disulfide (16h fast), relative abundance CySSG 50121

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glutathione, reduced (GSH) (16h fast), relative abundance GSH 50122

HMDP w/par

104

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glutathione, oxidized (GSSG) (16h fast), relative abundance GSSG 50123

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver S-methylglutathione (16h fast), relative abundance Me_glutathione 50124

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver ophthalmate (16h fast), relative abundance ophthalmate 50125

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 5-oxoproline (16h fast), relative abundance oxoproline 50126

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N-acetylglycine (16h fast), relative abundance acetyl_Gly 50127

HMDP w/par

96

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver dimethylglycine (16h fast), relative abundance diMe_Gly 50128

HMDP w/par

96

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glycine (16h fast), relative abundance Gly 50129

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver homoserine (16h fast), relative abundance homo_Ser 50130

HMDP w/par

104

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver serine (16h fast), relative abundance Ser 50131

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver threonine (16h fast), relative abundance Thr 50132

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver betaine (16h fast), relative abundance betaine 50133

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver betaine aldehyde (16h fast), relative abundance betaine_aldehyde 50134

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 3-methylcrotonylglycine (16h fast), relative abundance MeC_Gly 50135

HMDP w/par

98

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 4-guanidinobutanoate (16h fast), relative abundance guanidino 50136

HMDP w/par

94

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 1-methylimidazoleacetate (16h fast), relative abundance MeLAA 50137

HMDP w/par

91

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver histidine (16h fast), relative abundance His 50138

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glutarate (pentanedioate) (16h fast), relative abundance glutarate 50139

HMDP w/par

100

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N2-acetyllysine (16h fast), relative abundance acetyl_Lys 50140

HMDP w/par

105

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 2-aminoadipate (16h fast), relative abundance aminoadipate 50141

HMDP w/par

98

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver glutaroyl carnitine (16h fast), relative abundance GO_carnitine 50142

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver lysine (16h fast), relative abundance Lys 50143

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver pipecolate (16h fast), relative abundance pipecolate 50144

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver phenylalanine (16h fast), relative abundance Phe 50145

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver tyrosine (16h fast), relative abundance Tyr 50146

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 3-(4-hydroxyphenyl)lactate (16h fast), relative abundance HP_lactate 50147

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver phenylacetylglycine (16h fast), relative abundance PA_Gly 50148

HMDP w/par

105

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver phenol sulfate (16h fast), relative abundance phenol_sulfate 50149

HMDP w/par

103

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 5-methylthioadenosine (MTA) (16h fast), relative abundance MTA 50150

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver spermidine (16h fast), relative abundance spermidine 50151

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver anthranilate (16h fast), relative abundance anthranilate 50152

HMDP w/par

105

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver C-glycosyltryptophan (16h fast), relative abundance glycosyl_Trp 50153

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver kynurenine (16h fast), relative abundance kynurenine 50154

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver tryptophan (16h fast), relative abundance Trp 50155

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver kynurenate (16h fast), relative abundance kynurenate 50156

HMDP w/par

105

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver trans-4-hydroxyproline (16h fast), relative abundance hydroxy_Pro 50157

HMDP w/par

103

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver ornithine (16h fast), relative abundance ornithine 50158

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver urea (16h fast), relative abundance urea 50159

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver N-acetylornithine (16h fast), relative abundance acetylornithine 50160

HMDP w/par

103

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 5-aminovalerate (16h fast), relative abundance aminovalerate 50161

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver citrulline (16h fast), relative abundance citrulline 50162

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver homostachydrine (16h fast), relative abundance homostachydrine 50163

HMDP w/par

105

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver proline (16h fast), relative abundance Pro 50164

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver dimethylarginine (SDMA + ADMA) (16h fast), relative abundance SMDA_ADMA 50165

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver stachydrine (16h fast), relative abundance stachydrine 50166

HMDP w/par

104

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver hydroxyisovaleroyl carnitine (16h fast), relative abundance HV_carnitine 50167

HMDP w/par

104

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver isobutyrylcarnitine (16h fast), relative abundance IB_carnitine 50168

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver isoleucine (16h fast), relative abundance Ile 50169

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver isovalerylcarnitine (16h fast), relative abundance IV_carnitine 50170

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver isovalerylglycine (16h fast), relative abundance IV_Gly 50171

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver leucine (16h fast), relative abundance Leu 50172

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver 2-methylbutyroylcarnitine (16h fast), relative abundance MeB_carnitine 50173

HMDP w/par

105

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver methylglutaroylcarnitine (16h fast), relative abundance MeG_carnitine 50174

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver tigloylglycine (16h fast), relative abundance tigloyl_Gly 50175

HMDP w/par

92

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver tiglyl carnitine (16h fast), relative abundance tiglyl_carnitine 50176

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver valine (16h fast), relative abundance Val 50177

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno6

metabolite quantification

(none)

liver methylmalonate (MMA) (16h fast), relative abundance MMA 50178

HMDP w/par

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver erythronate (16h fast), relative abundance erythronate 50201

HMDP

102

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver glucosamine (16h fast), relative abundance glucosamine 50202

HMDP

93

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver erythrose (16h fast), relative abundance erythrose 50203

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver fructose (16h fast), relative abundance fructose 50204

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver maltose (16h fast), relative abundance maltose 50205

HMDP

94

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver mannose (16h fast), relative abundance mannose 50206

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver sorbitol (16h fast), relative abundance sorbitol 50207

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver maltotetraose (16h fast), relative abundance maltotetraose 50208

HMDP

100

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver 1,5-anhydroglucitol (1,5-AG) (16h fast), relative abundance anhydroglucitol 50209

HMDP

105

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver glucose (16h fast), relative abundance glucose 50210

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver glucuronate (16h fast), relative abundance glucuronate 50211

HMDP

104

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver glycerate (16h fast), relative abundance glycerate 50212

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver lactate (16h fast), relative abundance lactate 50213

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver 3-phosphoglycerate (16h fast), relative abundance phosphoglycerate 50214

HMDP

105

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver gluconate (16h fast), relative abundance gluconate 50215

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver 2-ketogulonate (16h fast), relative abundance ketogulonate 50216

HMDP

97

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver ribitol (16h fast), relative abundance ribitol 50217

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver ribose (16h fast), relative abundance ribose 50218

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver ribulose (16h fast), relative abundance ribulose 50219

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver xylitol (16h fast), relative abundance xylitol 50220

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver xylonate (16h fast), relative abundance xylonate 50221

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver 6-phosphogluconate (16h fast), relative abundance phosphogluconate 50222

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver UDP-glucose (16h fast), relative abundance UDP_glucose 50223

HMDP

105

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver arabonate (16h fast), relative abundance arabonate 50224

HMDP

85

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver ascorbate (Vitamin C) (16h fast), relative abundance ascorbate 50225

HMDP

94

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver glucarate (saccharate) (16h fast), relative abundance glucarate 50226

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver gulono-1,4-lactone (16h fast), relative abundance lactone 50227

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver threonate (16h fast), relative abundance threonate 50228

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver biopterin (16h fast), relative abundance biopterin 50229

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver 5-methyltetrahydrofolate (5MeTHF) (16h fast), relative abundance MeTHF 50230

HMDP

93

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver nicotinamide adenine dinucleotide (NAD+) (16h fast), relative abundance NAD 50231

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver nicotinamide (16h fast), relative abundance nicotinamide 50232

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

liver trigonelline (N'-methylnicotinate) (16h fast), relative abundance trigonelline 50233

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

pantothenate (16h fast), relative abundance pantothenate 50234

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

riboflavin (Vitamin B2) (16h fast), relative abundance riboflavin 50235

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

flavin adenine dinucleotide (FAD) (16h fast), relative abundance FAD 50236

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

flavin mononucleotide (FMN) (16h fast), relative abundance FMN 50237

HMDP

105

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

thiamin (Vitamin B1) (16h fast), relative abundance thiamin 50238

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

pyridoxate (16h fast), relative abundance pyridoxate 50239

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

citrate (16h fast), relative abundance citrate 50240

HMDP

104

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

fumarate (16h fast), relative abundance fumarate 50241

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

malate (16h fast), relative abundance malate 50242

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

succinylcarnitine (16h fast), relative abundance succinylcarnitine 50243

HMDP

93

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

cis-aconitate (16h fast), relative abundance aconitate 50244

HMDP

101

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

acetylphosphate (16h fast), relative abundance acetylphosphate 50245

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

phosphate (16h fast), relative abundance phosphate 50246

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

glycerol 2-phosphate (16h fast), relative abundance glycerol_phosphate 50247

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

methyl-alpha-glucopyranoside (16h fast), relative abundance glucopyranoside 50248

HMDP

105

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

N-glycolylneuraminate (16h fast), relative abundance glycolylneuraminate 50249

HMDP

100

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

ergothioneine (16h fast), relative abundance ergothioneine 50250

HMDP

106

m

16wks

N=1

2014

HMDPpheno7

metabolite quantification

(none)

erythritol (16h fast), relative abundance erythritol 50251

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

alpha-muricholate (16h fast), relative abundance alpha_muricholate 50301

HMDP

104

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

beta-muricholate (16h fast), relative abundance beta_muricholate 50302

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

chenodeoxycholate (16h fast), relative abundance chenodeoxycholate 50303

HMDP

105

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

cholate (16h fast), relative abundance cholate 50304

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

12-dehydrocholate (16h fast), relative abundance dehydrocholate 50305

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

6-beta-hydroxylithocholate (16h fast), relative abundance hydroxylithocholate 50306

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

tauro-beta-muricholate (16h fast), relative abundance tauro_muricholate 50307

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

taurocholate (16h fast), relative abundance taurocholate 50308

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

taurodeoxycholate (16h fast), relative abundance taurodeoxycholate 50309

HMDP

105

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

ursodeoxycholate (16h fast), relative abundance ursodeoxycholate 50310

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

acetylcarnitine (16h fast), relative abundance acetylcarnitine 50311

HMDP

103

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

carnitine (16h fast), relative abundance carnitine 50312

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

3-dehydrocarnitine (16h fast), relative abundance dehydrocarnitine 50313

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

malonylcarnitine (16h fast), relative abundance malonylcarnitine 50314

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

1,2-dipalmitoylglycerol (16h fast), relative abundance DPG_1_2 50315

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

1,3-dipalmitoylglycerol (16h fast), relative abundance DPG_1_3 50316

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

12-HETE (16h fast), relative abundance HETE_12 50317

HMDP

88

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

12-HEPE (16h fast), relative abundance HEPE_12 50318

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

18-HEPE (16h fast), relative abundance HEPE_18 50319

HMDP

104

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

15-HETE (16h fast), relative abundance HETE_15 50320

HMDP

94

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

5-HETE (16h fast), relative abundance HETE_5 50321

HMDP

105

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

docosahexaenoate (DHA; 22:6n3) (16h fast), relative abundance DHA 50322

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

dihomo-linolenate (20:3n3 or n6) (16h fast), relative abundance dihomo_linolenate 50323

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

docosapentaenoate (n3 DPA; 22:5n3) (16h fast), relative abundance DPA 50324

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

eicosapentaenoate (EPA; 20:5n3) (16h fast), relative abundance EPA 50325

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

linolenate [alpha or gamma; (18:3n3 or 6)] (16h fast), relative abundance linolenate 50326

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

valerylglycine (16h fast), relative abundance valerylglycine 50327

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

hexanoylglycine (16h fast), relative abundance hexanoylglycine 50328

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

butyrylglycine (16h fast), relative abundance butyrylglycine 50329

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

propionylcarnitine (16h fast), relative abundance propionylcarnitine 50330

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

azelate (nonanedioate) (16h fast), relative abundance azelate 50331

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

dodecanedioate (16h fast), relative abundance dodecanedioate 50332

HMDP

103

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

hexadecanedioate (16h fast), relative abundance hexadecanedioate 50333

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

tetradecanedioate (16h fast), relative abundance tetradecanedioate 50334

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

undecanedioate (16h fast), relative abundance undecanedioate 50335

HMDP

105

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

n-Butyl oleate (16h fast), relative abundance butyl_oleate 50336

HMDP

95

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

13-HODE + 9-HODE (16h fast), relative abundance HODE 50337

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

2-hydroxystearate (16h fast), relative abundance hydroxystearate 50338

HMDP

93

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

1-octadecanol (16h fast), relative abundance octadecanol 50339

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

ethanolamine (16h fast), relative abundance ethanolamine 50340

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

glycerol 3-phosphate (G3P) (16h fast), relative abundance G3P 50341

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

glycerol (16h fast), relative abundance glycerol 50342

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

choline (16h fast), relative abundance choline 50343

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

choline phosphate (16h fast), relative abundance choline_phosphate 50344

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver cytidine 5'-diphosphocholine (16h fast), relative abundance cytidine_DPC 50345

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver glycerophosphorylcholine (GPC) (16h fast), relative abundance GPC 50346

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver phosphoethanolamine (16h fast), relative abundance PEA 50347

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver inositol 1-phosphate (I1P) (16h fast), relative abundance I1P 50348

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver inositol 2-phosphate (I2P) (16h fast), relative abundance I2P 50349

HMDP

102

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver myo-inositol (16h fast), relative abundance myo_inositol 50350

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 3-hydroxybutyrate (BHBA) (16h fast), relative abundance BHBA 50351

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 1,2-propanediol (16h fast), relative abundance propanediol 50352

HMDP

104

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver arachidate (20:0) (16h fast), relative abundance arachidate 50353

HMDP

96

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver pentadecanoate (15:0) (16h fast), relative abundance pentadecanoate 50354

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver adrenate (22:4n6) (16h fast), relative abundance adrenate 50355

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver arachidonate (20:4n6) (16h fast), relative abundance arachidonate 50356

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver dihomo-linoleate (20:2n6) (16h fast), relative abundance dihomo_linoleate 50357

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver docosadienoate (22:2n6) (16h fast), relative abundance docosadienoate 50358

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver eicosenoate (20:1n9 or 11) (16h fast), relative abundance eicosenoate 50359

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 10-heptadecenoate (17:1n7) (16h fast), relative abundance heptadecenoate 50360

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver linoleate (18:2n6) (16h fast), relative abundance linoleate 50361

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver margarate (17:0) (16h fast), relative abundance margarate 50362

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver myristate (14:0) (16h fast), relative abundance myristate 50363

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver myristoleate (14:1n5) (16h fast), relative abundance myristoleate 50364

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver nonadecanoate (19:0) (16h fast), relative abundance nonadecanoate 50365

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 10-nonadecenoate (19:1n9) (16h fast), relative abundance nonadecenoate 50366

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver oleate (18:1n9) (16h fast), relative abundance oleate 50367

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver palmitate (16:0) (16h fast), relative abundance palmitate 50368

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver palmitoleate (16:1n7) (16h fast), relative abundance palmitoleate 50369

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver stearate (18:0) (16h fast), relative abundance stearate 50370

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver stearidonate (18:4n3) (16h fast), relative abundance stearidonate 50371

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver caprate (10:0) (16h fast), relative abundance caprate 50372

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver caproate (6:0) (16h fast), relative abundance caproate 50373

HMDP

99

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver laurate (12:0) (16h fast), relative abundance laurate 50374

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver pelargonate (9:0) (16h fast), relative abundance pelargonate 50375

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver malonate (propanedioate) (16h fast), relative abundance malonate 50376

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 1-linoleoylglycerol (1-monolinolein) (16h fast), relative abundance LOG 50377

HMDP

100

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 1-oleoylglycerol (1-monoolein) (16h fast), relative abundance OOG 50378

HMDP

104

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 1-palmitoylglycerol (1-monopalmitin) (16h fast), relative abundance POG 50379

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 1-stearoylglycerol (1-monostearin) (16h fast), relative abundance SOT 50380

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 1-docosahexaenoylglycerol (1-monodocosahexaenoin) (16h fast), relative abundance DHG 50381

HMDP

89

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver palmitoyl sphingomyelin (16h fast), relative abundance PO_sphingomyelin 50382

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver stearoyl sphingomyelin (16h fast), relative abundance SO_sphingomyelin 50383

HMDP

96

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver sphingosine (16h fast), relative abundance sphingosine 50384

HMDP

104

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 7-alpha-hydroxycholesterol (16h fast), relative abundance alpha_HOC 50385

HMDP

105

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver 7-beta-hydroxycholesterol (16h fast), relative abundance beta_HOC 50386

HMDP

105

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver cholesterol (16h fast), relative abundance cholesterol 50387

HMDP

106

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver vsqualene (16h fast), relative abundance squalene 50388

HMDP

93

m

16wks

N=1

2014

HMDPpheno8

metabolite quantification

(none)

liver corticosterone (16h fast), relative abundance corticosterone 50389

HMDP

92

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-arachidonoylglycerophosphocholine (16h fast), relative abundance AGPC 50401

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-docosahexaenoylglycerophosphocholine (16h fast), relative abundance DHGPC 50402

HMDP

105

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-docosahexaenoylglycerophosphoethanolamine (16h fast), relative abundance DHGPEA 50403

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-docosapentaenoylglycerophosphocholine (16h fast), relative abundance DPGPC 50404

HMDP

94

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-docosapentaenoylglycerophosphoethanolamine (16h fast), relative abundance DPGPEA 50405

HMDP

100

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-eicosatrienoylglycerophosphocholine (16h fast), relative abundance EGPC_1 50406

HMDP

91

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-eicosatrienoylglycerophosphocholine (16h fast), relative abundance EGPC_2 50407

HMDP

102

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-heptadecanoylglycerophosphocholine (16h fast), relative abundance HGPC 50408

HMDP

99

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-linoleoylglycerophosphocholine (16h fast), relative abundance LGPC_1 50409

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-linoleoylglycerophosphocholine (16h fast), relative abundance LGPC_2 50410

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-linoleoylglycerophosphoethanolamine (16h fast), relative abundance LGPEA_2 50411

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-myristoylglycerophosphocholine (16h fast), relative abundance MGPC 50412

HMDP

91

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-oleoylglycerophosphocholine (16h fast), relative abundance OGPC_1 50413

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-oleoylglycerophosphocholine (16h fast), relative abundance OGPC_2 50414

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-pentadecanoylglycerophosphocholine (16h fast), relative abundance PDGPC 50415

HMDP

93

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-palmitoylglycerophosphocholine (16h fast), relative abundance PGPC_1 50416

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-palmitoylglycerophosphocholine (16h fast), relative abundance PGPC_2 50417

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-palmitoleoylglycerophosphocholine (16h fast), relative abundance POGPC 50418

HMDP

105

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-stearoylglycerophosphocholine (16h fast), relative abundance SGPC_1 50419

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-stearoylglycerophosphocholine (16h fast), relative abundance SGPC_2 50420

HMDP

91

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-stearoylglycerophosphoethanolamine (16h fast), relative abundance SGPE 50421

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-arachidonoylglycerophosphoethanolamine (16h fast), relative abundance AGPA 50422

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-arachidonoylglycerophosphoethanolamine (16h fast), relative abundance AGPEA 50423

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-arachidonoylglycerophosphoinositol (16h fast), relative abundance AGPI 50424

HMDP

104

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-linoleoylglycerophosphoethanolamine (16h fast), relative abundance LGPEA_1 50425

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-oleoylglycerophosphoethanolamine (16h fast), relative abundance OGPEA_1 50426

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-oleoylglycerophosphoethanolamine (16h fast), relative abundance OGPEA_2 50427

HMDP

103

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-oleoylglycerophosphoinositol (16h fast), relative abundance OGPI 50428

HMDP

100

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 2-palmitoylglycerophosphoethanolamine (16h fast), relative abundance PGEA 50429

HMDP

93

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-palmitoylglycerophosphoethanolamine (16h fast), relative abundance PGPEA 50430

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-palmitoylglycerophosphoinositol (16h fast), relative abundance PGPI 50431

HMDP

106

m

16wks

N=1

2014

HMDPpheno9

metabolite quantification

(none)

liver 1-stearoylglycerophosphoinositol (16h fast), relative abundance SGPI 50432

HMDP

106

m

16wks

N=1

2014

Jentsch1

operant conditioning chamber

(none)

number of initiated trials per daily session, acquisition phase [n] acq_initiated_trials 40301

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

number of trials with no choice made in first 30 s, acquisition phase [n] acq_no_choice 40302

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average number of anticipatory responses per trial, acquisition phase [n] acq_anticipatory 40303

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to initiate trial, acquisition phase [s] acq_latency_trial 40304

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to make correct choice, acquisition phase [s] acq_latency_correct 40305

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to retrieve food reward, acquisition phase [s] acq_latency_reward 40306

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

number of initiated trials per daily session, reversal phase [n] revers_init_trials 40307

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

number of trials with no choice made in first 30 s, reversal phase [n] revers_no_choice 40308

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average number of anticipatory responses per trial, reversal phase [n] revers_anticipatory 40309

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to initiate trial, reversal phase [s] revers_latency_trial 40310

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to make correct choice, reversal phase [s] revers_latency_correct 40311

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to retrieve food reward, reversal phase [s] revers_latency_reward 40312

BXD w/par

53

m

17wks

N=3

2011

Jentsch2

operant conditioning chamber

cocaine

number of sessions (days) required to reach criteria for self-administration (FR1 reinforcement schedule) [d] acquisition_FR1 49701

BXD

4

both

8-17wks

N=8

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 1 - self administration: number of infusions earned [n] infusions_FR1 49702 day 1 day 3 day 5 last day

BXD

4

both

8-17wks

N=8

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 1 - discrimination index between active and inactive levers [%] discrimination_FR1 49706 day 1 day 3 day 5 last day

BXD

4

both

8-17wks

N=7

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 1 - time-out: number of responses [n] timeout_FR1 49710 day 1 day 3 day 5 last day

BXD

4

both

8-17wks

N=7

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 2 - self administration: number of infusions earned [n] infusions_FR2 49714 day 1 day 2 day 4

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 2 - discrimination index between active and inactive levers [%] discrimination_FR2 49717 day 1 day 2 day 4

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 2 - time-out: number of responses [n] timeout_FR2 49720 day 1 day 2 day 4

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 5 - self administration: number of infusions earned [n] infusions_FR5 49723 day 1 day 3 day 5

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 5 - discrimination index between active and inactive levers [%] discrimination_FR5 49726 day 1 day 3 day 5

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 5 - time-out: number of responses [n] timeout_FR5 49729 day 1 day 3 day 5

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

horizontal beam breaks [n] activity 49732 baseline 5 mg/kg 10 mg/kg 20 mg/kg

BXD

4

f

8-17wks

N=13

2013

Project1032

operant conditioning chamber

(none)

number of infusions earned (intravenous self administration), saline [n] infusions_control 111414 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

number of infusions earned (intravenous self administration), cocaine [n] infusions_cocaine 111424 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

number of infusions earned (intravenous self administration) combined, saline [n] infusions_combined_control 111434 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

number of infusions earned (intravenous self administration), cocaine [n] infusions_combined_cocaine 111437 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

percentage of lever presses that are active (intravenous self administration), saline [%] active_pct_control 111440 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

percentage of lever presses that are active (intravenous self administration), cocaine [%] active_pct_cocaine 111450 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

percentage of lever presses that are active (intravenous self administration) combined, saline [%] active_pct_combined_control 111460 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

percentage of lever presses that are active (intravenous self administration) combined, cocaine [%] active_pct_combined_cocaine 111463 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

number of active lever presses (during infusions and timeouts) (intravenous self administration), saline [n] active_control 111466 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

number of active lever presses (during infusions and timeouts) (intravenous self administration), cocaine [n] active_cocaine 111476 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

number of active lever presses (during infusions and timeouts) (intravenous self administration) combined, saline [n] active_combined_control 111486 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

number of active lever presses (during infusions and timeouts) (intravenous self administration) combined, cocaine [n] active_combined_cocaine 111489 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

number of inactive lever presses (intravenous self administration), saline [n] inactive_control 111492 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

number of inactive lever presses (intravenous self administration), cocaine [n] inactive_cocaine 111502 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

number of inactive lever presses (intravenous self administration) combined, saline [n] inactive_combined_control 111512 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

cocaine

number of inactive lever presses (intravenous self administration) combined, cocaine [n] inactive_combined_cocaine 111515 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=2

2020

Project1032

operant conditioning chamber

(none)

session duration (120 min max) (intravenous self administration), saline [min] session_time_control 111518 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=3

2020

Project1032

operant conditioning chamber

cocaine

session duration (120 min max) (intravenous self administration), cocaine [min] session_time_cocaine 111528 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10

HMDP

66

both

9-15wks

N=3

2020

Project1032

operant conditioning chamber

(none)

session duration (120 min max) (intravenous self administration) combined, saline [min] session_time_combined_control 111538 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=3

2020

Project1032

operant conditioning chamber

cocaine

session duration (120 min max) (intravenous self administration) combined, cocaine [min] session_time_combined_cocaine 111541 days 1-4 days 5-7 days 8-10

HMDP

66

both

9-15wks

N=3

2020

Project1061

fear conditioning test

(none)

cohort cohort 113862 measure and covariate nicotine saline

BXD w/par

31

both

N=8

2021

Project1061

fear conditioning test

(none)

dob dob 113864 categorical informational nicotine saline

BXD w/par

31

both

N=8

2021

Project1061

fear conditioning test

(none)

baseline [%] baseline 113866 nicotine saline

BXD w/par

31

both

N=8

2021

Project1061

fear conditioning test

(none)

immediate [%] immediate 113868 nicotine saline

BXD w/par

31

both

N=8

2021

Project1061

fear conditioning test

(none)

context [%] context 113870 nicotine saline

BXD w/par

31

both

N=8

2021

Project1061

fear conditioning test

(none)

precs [%] precs 113872 nicotine saline

BXD w/par

31

both

N=8

2021

Project1061

fear conditioning test

(none)

cs [%] cs 113874 nicotine saline

BXD w/par

31

both

N=8

2021

Project1204

None

(none)

Generalized_Lat_D1 Generalized_Lat_D1 130806

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D2 Generalized_Lat_D2 130807

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D3 Generalized_Lat_D3 130808

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D4 Generalized_Lat_D4 130809

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D5 Generalized_Lat_D5 130810

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D6 Generalized_Lat_D6 130811

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D7 Generalized_Lat_D7 130812

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_D8 Generalized_Lat_D8 130813

BXD

51

p

N=1

2024

Project1204

None

(none)

Generalized_Lat_Ret Generalized_Lat_Ret 130814

BXD

51

p

N=1

2024

Project1204

None

(none)

Kindling_Mean Kindling_Mean 130815

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D1 Myoclonic_Lat_D1 130816

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D2 Myoclonic_Lat_D2 130817

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D3 Myoclonic_Lat_D3 130818

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D4 Myoclonic_Lat_D4 130819

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D5 Myoclonic_Lat_D5 130820

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D6 Myoclonic_Lat_D6 130821

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D7 Myoclonic_Lat_D7 130822

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_D8 Myoclonic_Lat_D8 130823

BXD

51

p

N=1

2024

Project1204

None

(none)

Myoclonic_Lat_Ret Myoclonic_Lat_Ret 130824

BXD

51

p

N=1

2024

Project1204

None

(none)

Audiogenic_seizure Audiogenic_seizure 130825

BXD

25

p

N=1

2024

Project1204

None

(none)

AudioSeizOccur AudioSeizOccur 130826

BXD

25

p

N=1

2024

Project1204

None

(none)

EtOH_withdrawal_seizure EtOH_withdrawal_seizure 130827

BXD

27

p

N=1

2024

Project1204

None

(none)

WdrawalAUC25EtOHPyr WdrawalAUC25EtOHPyr 130828

BXD

27

p

N=1

2024

Project1204

None

(none)

High_pressure_seizure_ High_pressure_seizure_ 130829

BXD

23

p

N=1

2024

Project1204

None

(none)

COCclonSEIZ COCclonSEIZ 130830

BXD

26

p

N=1

2024

Project1204

None

(none)

COCtonSEIZ COCtonSEIZ 130831

BXD

26

p

N=1

2024

Project1204

None

(none)

High_pressure_seizure_.1 High_pressure_seizure_.1 130832

BXD

23

p

N=1

2024

Project1204

None

(none)

Audiogenic_seizure.1 Audiogenic_seizure.1 130833

BXD

25

p

N=1

2024

Project1204

None

(none)

SeizureThresh1000atm SeizureThresh1000atm 130834

BXD

23

p

N=1

2024

Project1204

None

(none)

PTZSEIZ PTZSEIZ 130835

BXD

24

p

N=1

2024

Project1204

None

(none)

Audiogenic_seizure.2 Audiogenic_seizure.2 130836

BXD

15

p

N=1

2024

Project1204

None

(none)

Clonic_tonic_seizure Clonic_tonic_seizure 130837

BXD

15

p

N=1

2024

Project1204

None

(none)

SeizureSeverity SeizureSeverity 130838

BXD

9

p

N=1

2024

Project1204

None

(none)

M_HAND_BASELINE M_HAND_BASELINE 130839

BXD

31

p

N=1

2024

Project1204

None

(none)

F_HAND_BASELINE F_HAND_BASELINE 130840

BXD

27

p

N=1

2024

Project1204

None

(none)

PCTCLONTON PCTCLONTON 130841

BXD

9

p

N=1

2024

Project1204

None

(none)

AudSEIZFreq AudSEIZFreq 130842

BXD

25

p

N=1

2024

Project1204

None

(none)

HAND_BASELINE HAND_BASELINE 130843

BXD

31

p

N=1

2024

Project1204

None

(none)

AudSEIZSeverity AudSEIZSeverity 130844

BXD

23

p

N=1

2024

Project1204

None

(none)

SeizureSusc1000atm SeizureSusc1000atm 130845

BXD

23

p

N=1

2024

Project1204

None

(none)

WdrawalAUC25AirPyr WdrawalAUC25AirPyr 130846

BXD

27

p

N=1

2024

Project1204

None

(none)

M_HIC_SCORE M_HIC_SCORE 130847

BXD

26

p

N=1

2024

Project1204

None

(none)

F_HIC_SCORE F_HIC_SCORE 130848

BXD

22

p

N=1

2024

Project1204

None

(none)

M_HAND_6HOURS M_HAND_6HOURS 130849

BXD

31

p

N=1

2024

Project1204

None

(none)

F_HAND_6HOURS F_HAND_6HOURS 130850

BXD

27

p

N=1

2024

Project1204

None

(none)

F_HAND_4HOURS F_HAND_4HOURS 130851

BXD

27

p

N=1

2024

Project1204

None

(none)

BLHIC BLHIC 130852

BXD

21

p

N=1

2024

Project1204

None

(none)

NOwdrwlHICcorrPeak NOwdrwlHICcorrPeak 130853

BXD

21

p

N=1

2024

Project1204

None

(none)

NOwdrwlHIC NOwdrwlHIC 130854

BXD

21

p

N=1

2024

Project1204

None

(none)

CEWHic CEWHic 130855

BXD

10

p

N=1

2024

Project1204

None

(none)

CEWHic.1 CEWHic.1 130856

BXD

10

p

N=1

2024

Project1204

None

(none)

CEWHic.2 CEWHic.2 130857

BXD

10

p

N=1

2024

Project1204

None

(none)

CEWHic_All CEWHic_All 130858

BXD

18

p

N=1

2024

Project1204

None

(none)

EthanolWithdrawHIC EthanolWithdrawHIC 130859

BXD

23

p

N=1

2024

Project1204

None

(none)

SerumT4 SerumT4 130860

BXD

9

p

N=1

2024

Project1204

None

(none)

SerumT4.1 SerumT4.1 130861

BXD

9

p

N=1

2024

Project1204

None

(none)

EtOHWdrwHICcorrAUC EtOHWdrwHICcorrAUC 130862

BXD

21

p

N=1

2024

Project1204

None

(none)

ATPaseActivity ATPaseActivity 130863

BXD

15

p

N=1

2024

Project1204

None

(none)

Mg2_ATPaseActivity Mg2_ATPaseActivity 130864

BXD

15

p

N=1

2024

Project1204

None

(none)

Na_K_ATPaseActivity Na_K_ATPaseActivity 130865

BXD

15

p

N=1

2024

Project1204

None

(none)

HIC7hrPstEtOH HIC7hrPstEtOH 130866

BXD

25

p

N=1

2024

Project1204

None

(none)

SALOFA SALOFA 130867

BXD

22

p

N=1

2024

Project1204

None

(none)

EtOHLocACT EtOHLocACT 130868

BXD

22

p

N=1

2024

Project1204

None

(none)

EtOHataxia EtOHataxia 130869

BXD

10

p

N=1

2024

Project1204

None

(none)

NOwdrwlHIC.1 NOwdrwlHIC.1 130870

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHTotCons EtOHTotCons 130871

BXD

19

p

N=1

2024

Project1204

None

(none)

EtOHWdrawal EtOHWdrawal 130872

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHPrefRat EtOHPrefRat 130873

BXD

19

p

N=1

2024

Project1204

None

(none)

EtOH_SAL_LOC_ACT EtOH_SAL_LOC_ACT 130874

BXD

22

p

N=1

2024

Project1204

None

(none)

BEC1.5g_kg BEC1.5g_kg 130875

BXD

27

p

N=1

2024

Project1204

None

(none)

OpenFieldSal OpenFieldSal 130876

BXD

22

p

N=1

2024

Project1204

None

(none)

WaterPrefvsEtOH WaterPrefvsEtOH 130877

BXD

21

p

N=1

2024

Project1204

None

(none)

WaterPrefvsSacc WaterPrefvsSacc 130878

BXD

21

p

N=1

2024

Project1204

None

(none)

HIC_SCORE HIC_SCORE 130879

BXD

26

p

N=1

2024

Project1204

None

(none)

M_HAND_4HOURS M_HAND_4HOURS 130880

BXD

31

p

N=1

2024

Project1204

None

(none)

M_HAND_7HOURS M_HAND_7HOURS 130881

BXD

31

p

N=1

2024

Project1204

None

(none)

F_HAND_7HOURS F_HAND_7HOURS 130882

BXD

27

p

N=1

2024

Project1204

None

(none)

HAND_4HOURS HAND_4HOURS 130883

BXD

31

p

N=1

2024

Project1204

None

(none)

HAND_6HOURS HAND_6HOURS 130884

BXD

31

p

N=1

2024

Project1204

None

(none)

HAND_7HOURS HAND_7HOURS 130885

BXD

31

p

N=1

2024

Project1204

None

(none)

SaccCons SaccCons 130886

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHPref EtOHPref 130887

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHCons3_inTap EtOHCons3_inTap 130888

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHCons10_inTap EtOHCons10_inTap 130889

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHCons3_inSacc EtOHCons3_inSacc 130890

BXD

21

p

N=1

2024

Project1204

None

(none)

EtOHCons10_inSacc EtOHCons10_inSacc 130891

BXD

21

p

N=1

2024

Project1204

None

(none)

Ca2_StimATPaseAct Ca2_StimATPaseAct 130892

BXD

26

p

N=1

2024

Project1204

None

(none)

Mg2_StimATPaseAct Mg2_StimATPaseAct 130893

BXD

26

p

N=1

2024

Project1204

None

(none)

HalCatalepsy HalCatalepsy 130894

BXD

28

p

N=1

2024

Project1204

None

(none)

DATBmax DATBmax 130895

BXD

23

p

N=1

2024

Project1204

None

(none)

LongevityMean_F1988_DF LongevityMean_F1988_DF 130896

BXD

23

p

N=1

2024

Project1204

None

(none)

LongevityMedian_F1988 LongevityMedian_F1988 130897

BXD

23

p

N=1

2024

Rosen1

histopathology

(none)

corpus callosum area [mm²] corpus_callosum 47801

BXD w/par

78

both

varies

N=2

2012

Rosen1

histopathology

(none)

corpus callosum area, adjusted [mm²] corpus_callosum_adj 47802

BXD w/par

78

both

varies

N=2

2012

Rosen1

colony observation

(none)

age (local parameter) [d] age 47803

BXD w/par

78

both

varies

N=2

2012

Rosen2

histopathology

(none)

lateral septum volume [mm³] lateral_septum 47901

BXD w/par

71

both

varies

N=3

2012

Rosen2

histopathology

(none)

lateral septum volume, adjusted [mm³] lateral_septum_adj 47902

BXD w/par

71

both

varies

N=2

2012

Rosen2

colony observation

(none)

age (local parameter) [d] age 47903

BXD w/par

71

both

varies

N=3

2012

Schalkwyk2

RNA expression profiling

(none)

miR-15b, hippocampal microRNA expression, relative miR15b 48101

BXD w/par

26

m

15-16wks

N=4

2012

Schalkwyk2

RNA expression profiling

(none)

miR-31, hippocampal microRNA expression, relative miR31 48102

BXD w/par

26

m

15-16wks

N=4

2012

Schalkwyk2

RNA expression profiling

(none)

miR-34c, hippocampal microRNA expression, relative miR34c 48103

BXD w/par

26

m

15-16wks

N=4

2012

Schalkwyk2

RNA expression profiling

(none)

miR-212, hippocampal microRNA expression, relative miR212 48104

BXD w/par

26

m

15-16wks

N=4

2012

Schalkwyk2

RNA expression profiling

(none)

miR-301a, hippocampal microRNA expression, relative miR301a 48105

BXD w/par

26

m

15-16wks

N=4

2012

Schoonjans1

body weight

high-fat diet

body weight at 8 weeks of age [g] bw_8wks 112632 CD HFD

BXD w/par

36

m

8wks

N=5

2021

Schoonjans1

body weight

high-fat diet

body weight prior to glucose kinetic test, at 20 wks of age [g] bw_pre_gluc_kinetic 112634 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

body weight

high-fat diet

body weight after glucose kinetic test, at 20 wks of age [g] bw_post_gluc_kinetic 112636 CD HFD

BXD w/par

31

m

20wks

N=5

2021

Schoonjans1

body weight

high-fat diet

body weight at sacrifice, 29 wks of age [g] bw_29wks 112638 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

glucose tolerance

high-fat diet

glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 0 min [mmol/L] gluc_kinetic_t0 112640 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

glucose tolerance

high-fat diet

glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 30 min [mmol/L] gluc_kinetic_t30 112642 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

glucose tolerance

high-fat diet

glucose, glucose kinetic test (Ensure Plus oral gavage, overday fast), at 20 wks of age, after 60 min [mmol/L] gluc_kinetic_t60 112644 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] oxo_CA_plasma_t0 112646 CD HFD

BXD w/par

21

m

20wks

N=3

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 7-ketodeoxycholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] keto_DCA_plasma_t0 112648 CD HFD

BXD w/par

35

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] aMCA_plasma_t0 112650 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid β-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] bMCA_plasma_t0 112652 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] CA_plasma_t0 112654 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] CDCA_plasma_t0 112656 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] DCA_plasma_t0 112658 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] GCA_plasma_t0 112660 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid γ-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] MCA_plasma_t0 112662 CD HFD

BXD w/par

18

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TaMCA_plasma_t0 112664 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-β-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TbMCA_plasma_t0 112666 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TCA_plasma_t0 112668 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TCDCA_plasma_t0 112670 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TDCA_plasma_t0 112672 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] THDCA_plasma_t0 112674 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] TUDCA_plasma_t0 112676 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] UDCA_plasma_t0 112678 CD HFD

BXD w/par

35

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ω-muricholic acid, glucose kinetic test, at 20 wks of age, at 0 min [ng/mL] wMCA_plasma_t0 112680 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] oxo_CA_plasma_t30 112682 CD HFD

BXD w/par

17

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 7-ketodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] keto_DCA_plasma_t30 112684 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] aMCA_plasma_t30 112686 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid β-muricholic acid, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] bMCA_plasma_t30 112688 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] CA_plasma_t30 112690 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] CDCA_plasma_t30 112692 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] DCA_plasma_t30 112694 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] GCA_plasma_t30 112696 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid γ-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] MCA_plasma_t30 112698 CD HFD

BXD w/par

18

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TaMCA_plasma_t30 112700 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TbMCA_plasma_t30 112702 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TCA_plasma_t30 112704 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TCDCA_plasma_t30 112706 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TDCA_plasma_t30 112708 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] THDCA_plasma_t30 112710 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] TUDCA_plasma_t30 112712 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] UDCA_plasma_t30 112714 CD HFD

BXD w/par

33

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ω-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min [ng/mL] wMCA_plasma_t30 112716 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 3-oxocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] oxo_CA_plasma_t60 112718 CD HFD

BXD w/par

19

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid 7-ketodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] keto_DCA_plasma_t60 112720 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] aMCA_plasma_t60 112722 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid β-muricholic acid, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] bMCA_plasma_t60 112724 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid cholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] CA_plasma_t60 112726 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid chenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] CDCA_plasma_t60 112728 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid deoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] DCA_plasma_t60 112730 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid glycocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] GCA_plasma_t60 112732 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid γ-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] MCA_plasma_t60 112734 CD HFD

BXD w/par

15

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-α-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TaMCA_plasma_t60 112736 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TbMCA_plasma_t60 112738 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurocholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TCA_plasma_t60 112740 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurochenodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TCDCA_plasma_t60 112742 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TDCA_plasma_t60 112744 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid taurohyodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] THDCA_plasma_t60 112746 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid tauroursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] TUDCA_plasma_t60 112748 CD HFD

BXD w/par

36

m

20wks

N=4

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ursodeoxycholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] UDCA_plasma_t60 112750 CD HFD

BXD w/par

33

m

20wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

plasma bile acid ω-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 60 min [ng/mL] wMCA_plasma_t60 112752 CD HFD

BXD w/par

36

m

20wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid 3-oxocholic acid amount in feces, at 24 wks [ng/mL] oxo_CA_feces 112754 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid 7-ketodeoxycholic acid amount in feces, at 24 wks [ng/mL] keto_DCA_feces 112756 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid 7-ketolithocholic acid amount in feces, at 24 wks [ng/mL] keto_LCA_feces 112758 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid α-muricholic acid amount in feces, at 24 wks [ng/mL] aMCA_feces 112760 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid β-muricholic acid amount in feces, at 24 wks [ng/mL] bMCA_feces 112762 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid cholic acid amount in feces, at 24 wks [ng/mL] CA_feces 112764 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid chenodeoxycholic acid amount in feces, at 24 wks [ng/mL] CDCA_feces 112766 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid deoxycholic acid amount in feces, at 24 wks [ng/mL] DCA_feces 112768 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycocholic acid amount in feces, at 24 wks [ng/mL] GCA_feces 112770 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycochenodeoxycholic acid amount in feces, at 24 wks [ng/mL] GCDCA_feces 112772 CD HFD

BXD w/par

35

m

24wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycohyodeoxycholic acid amount in feces, at 24 wks [ng/mL] GHDCA_feces 112774 CD HFD

BXD w/par

14

m

24wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycolithocholic acid amount in feces, at 24 wks [ng/mL] GLCA_feces 112776 CD HFD

BXD w/par

20

m

24wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycoursodeoxycholic acid amount in feces, at 24 wks [ng/mL] GUDCA_feces 112778 CD HFD

BXD w/par

17

m

24wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid isodeoxycholic acid amount in feces, at 24 wks [ng/mL] IsoDCA_feces 112780 CD HFD

BXD w/par

36

m

24wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid 3-oxocholic acid amount in feces, at 24 wks [ng/mL] LCA_feces 112782 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid γ-muricholic acid amount in feces, at 24 wks [ng/mL] MCA_feces 112784 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid murocholic acid amount in feces, at 24 wks [ng/mL] MDCA_feces 112786 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid tauro-α-muricholic acid in feces, at 24 wks [ng/mL] TaMCA_feces 112788 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid tauro-β-muricholic acid amount in feces, at 24 wks [ng/mL] TbMCA_feces 112790 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurocholic acid amount in feces, at 24 wks [ng/mL] TCA_feces 112792 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurocholic acid amount in feces, at 24 wks [ng/mL] TCDCA_feces 112794 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurodeoxycholic acid amount in feces, at 24 wks [ng/mL] TDCA_feces 112796 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurohyodeoxycholic acid amount in feces, at 24 wks [ng/mL] THDCA_feces 112798 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurolithocholic acid amount in feces, at 24 wks [ng/mL] TLCA_feces 112800 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid tauroursodeoxycholic acid amount in feces, at 24 wks [ng/mL] TUDCA_feces 112802 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid ursodeoxycholic acid amount in feces, at 24 wks [ng/mL] UDCA_feces 112804 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid ω-muricholic acid in feces, at 24 wks [ng/mL] wMCA_feces 112806 CD HFD

BXD w/par

36

m

24wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid 3-oxocholic acid amount in liver, at 29 wks [ng/mL] oxo_CA_liver 112808 CD

BXD w/par

2

m

29wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid 7-ketodeoxycholic acid amount in liver, at 29 wks [ng/mL] keto_DCA_liver 112809 CD HFD

BXD w/par

12

m

29wks

N=2

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid α-muricholic acid amount in liver, at 29 wks [ng/mL] aMCA_liver 112812 CD HFD

BXD w/par

36

m

29wks

N=3

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid β-muricholic acid amount in liver, at 29 wks [ng/mL] bMCA_liver 112814 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid cholic acid amount in liver, at 29 wks [ng/mL] CA_liver 112816 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid chenodeoxycholic acid amount in liver, at 29 wks [ng/mL] CDCA_liver 112818 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid deoxycholic acid amount in liver, at 29 wks [ng/mL] DCA_liver 112820 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycocholic acid amount in liver, at 29 wks [ng/mL] GCA_liver 112822 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycochenodeoxycholic acid amount in liver, at 29 wks [ng/mL] GCDCA_liver 112824 CD HFD

BXD w/par

3

m

29wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycolithocholic acid amount in liver, at 29 wks [ng/mL] GLCA_liver 112827 CD HFD

BXD w/par

3

m

29wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid glycoursodeoxycholic acid amount in liver, at 29 wks [ng/mL] GUDCA_liver 112829 CD HFD

BXD w/par

34

m

29wks

N=3

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid isodeoxycholic acid amount in liver, at 29 wks [ng/mL] IsoDCA_liver 112831 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid murocholic acid amount in liver, at 29 wks [ng/mL] MDCA_liver 112833 CD HFD

BXD w/par

10

m

29wks

N=1

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid tauro-α-muricholic acid amount in liver, at 29 wks [ng/mL] TaMCA_liver 112835 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid tauro-β-muricholic acid amount in liver, at 29 wks [ng/mL] TbMCA_liver 112837 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurocholic acid amount in liver, at 29 wks [ng/mL] TCA_liver 112839 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurochenodeoxycholic acid amount in liver, at 29 wks [ng/mL] TCDCA_liver 112841 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurodeoxycholic acid amount in liver, at 29 wks [ng/mL] TDCA_liver 112843 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurohyodeoxycholic acid amount in liver, at 29 wks [ng/mL] THDCA_liver 112845 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid taurolithocholic acid amount in liver, at 29 wks [ng/mL] TLCA_liver 112847 CD HFD

BXD w/par

23

m

29wks

N=3

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid tauroursodeoxycholic acid amount in liver, at 29 wks [ng/mL] TUDCA_liver 112849 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

biomarker quantification

high-fat diet

bile acid ω-muricholic acid amount in liver, at 29 wks [ng/mL] wMCA_liver 112853 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

liver weight [g] liver_wt 112855 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

spleen weight [g] spleen_wt 112857 CD HFD

BXD w/par

35

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

kidney weight (both) [g] kidney_wt 112859 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

subcutaneous adipose tissue weight [g] subcut_adip_wt 112861 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

epididymal fat pad weight [g] epid_fat_wt 112863 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

gastrocnemius muscle weight [g] gastroc_wt 112865 CD HFD

BXD w/par

35

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

soleus muscle weight [g] soleus_wt 112867 CD HFD

BXD w/par

35

m

29wks

N=5

2021

Schoonjans1

organ weights

high-fat diet

cecum weight [g] cecum_wt 112869 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schoonjans1

organ dimensions

high-fat diet

small intestine length [cm] small_intestine_length 112871 CD HFD

BXD w/par

36

m

29wks

N=5

2021

Schughart2

body weight

influenza A (H1N1) virus

body weight, pre-infection [g] bw 49601

BXD w/par

56

f

9-18wks

N=6

2012

Schughart2

body weight

influenza A (H1N1) virus

body weight as percent of baseline [%] pctbw 49602 day 1 day 3 day 7

BXD w/par

56

f

9-18wks

N=6

2012

Schughart2

health assessment

influenza A (H1N1) virus

survival, post-infection [d] survival_days 49606

BXD w/par

56

f

9-18wks

N=6

2012

Schughart2

health assessment

influenza A (H1N1) virus

susceptibility to viral infection (0=susceptible; 1=resistant) [designation] susceptibility 49607

BXD w/par

56

f

9-18wks

N=6

2012

Spijker1

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR 40601 65dB 70dB 75dB 80dB 90dB 100dB 110dB 120dB

BXD w/par

39

m

8wks

N=11

2011

Spijker1

acoustic startle test

(none)

prepulse inhibition (PPI), 120 dB startle intensity [%] PPI 40613 120 dB startle intensity with prepulse stimulus: 65dB 70dB 75dB 80dB

BXD w/par

36

m

8wks

N=9

2011

Spijker1

acoustic startle test

(none)

prepulse intensity 10 dB lower than startle threshold [amplitude] PPI_belowST 40617

BXD w/par

36

m

8wks

N=9

2011

Spijker1

acoustic startle test

(none)

startle threshold, minimum stimulus intensity where startle is significant compared to null period [dB] startle_threshold 40618

BXD w/par

39

m

8wks

N=11

2011

Spijker1

choice serial reaction time task

(none)

percentage of total Reponses that are correct, stimulus duration fixed, 1s [%] accuracy_SD1 40619

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

percentage of events that are omission errors, stimulus duration fixed, 1s [%] omission_SD1 40620

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

correct response latency, stimulus duration fixed, 1s [s] latency_correct 40621

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

mode of correct response latencies, stimulus duration fixed, 1s [s] latency_mode 40622

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

individual variability of correct response latency [s] variability_SD1 40623

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

latency between correct response and head entry detected in food magazine, stimulus duration fixed, 1s [s] latency_reward 40624

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

number of initiated trials, stimulus duration 1s [n] trials_initiated 40625

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

percentage of total responses that are correct, stimulus duration variable [%] accuracy_SDvar 40626

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

percentage of events that are omission errors, stimulus duration variable [%] omission_SDvar 40627

BXD w/par

43

m

8wks

N=13

2011

Filter Table Results